A judgment call

Article Type
Changed
Display Headline
A judgment call

A 22-year-old African American man with sickle cell disease comes to the in his joints and chest—a presentation similar to those of his previous sickle cell crises. He is given intravenous fluids for dehydration and morphine sulfate for pain via a peripheral line, and he is admitted to the hospital.

Shortly afterward, the peripheral line becomes infiltrated. After failed attempts at peripheral cannulation, central venous cannulation via an internal jugular site is considered.

Figure 1.
The patient alerts us that he has had multiple “neck lines” in the past and that these had been difficult to place. With this in mind, we attempt to place a triple-lumen catheter under ultrasonographic guidance and with the use of sterile precautions and the Seldinger technique. On the first attempt, the guidewire cannot be advanced beyond 4 cm, and the attempt is terminated. On the second attempt, the guidewire advances freely, but as the catheter is advanced, slight resistance is felt at 4 cm and again at 10 cm. This resistance is overcome with slight pressure, and subsequent advancement meets with no further resistance. After confirming nonpulsatile blood return in all three lumens, we suture the catheter at 14 cm from the insertion site. A chest radiograph (Figure 1) is requested to confirm placement.

WHERE IS THE CATHETER TIP?

Figure 2.
At first look, the catheter appears to broadly follow an expected trajectory. However, a closer look shows that the catheter is not properly positioned: although it is difficult to see, the tip appears to project beyond the main carina (see arrow), an important landmark to identify catheter tip placement. It appears to go beyond the expected site of the junction of the superior vena cava and the right atrium. Also, at the level of the right main-stem bronchus, the catheter appears to curve with an infero-lateral convexity. To confirm the placement, a lateral view is obtained (Figure 2). As evident in this view, the internal jugular catheter does not terminate at the desirable level, but rather turns posteriorly to extend into the azygos vein (see arrow). The lateral view was required in this patient to ascertain the exact location of the catheter tip.

HAZARDS OF ABERRANT LINE PLACEMENT

Central venous catheters are commonly used to give various infusions (eg, parenteral nutrition), to draw blood, and to monitor the central venous pressure.1 The internal jugular vein is one of the preferred veins for central venous access.1,2 Normally, the anatomy of the jugular venous system and the design of the catheter facilitate proper insertion. Occasionally, however, despite proper technique, the tip of the catheter may not terminate at the desired level, resulting in aberrant placement in the internal thoracic vein, superior vena cava, azygos vein, accessory hemiazygos vein, or axillary vein.1–8

The use of chest radiographs to establish the correct placement of internal jugular and subclavian lines has been advocated and is routinely practiced.6,7 Obtaining a chest x-ray to confirm line placement is particularly important in patients with prior multiple and difficult catheterizations. The lateral view is seldom obtained when confirming central neck line placement, but when the anteroposterior view is not reassuring, it may be prudent to obtain this alternate view.

In a large retrospective analysis,9 cannulation of the azygos arch occurred in about 1.2% of insertions, and the rate was about seven times higher when the left jugular vein was used than when the right one was used. A smaller study gave the frequency of azygos arch cannulation as 0.7%.10

All procedure-related complications of central line insertion in the neck can also occur with aberrant azygos vein cannulation. These include infection, bacteremia, pneumothorax, hemothorax, arterial puncture, and various other mechanical complications. It should be noted that aberrant cannulation of the azygos arch is particularly hazardous, and that complication rates are typically higher. These complications are mainly due to the smaller vascular lumen and to the direction of blood flow in the azygos venous system.

 

 

KNOWING THE ANATOMY IS CRUCIAL

Knowledge of venous anatomy and its variants is crucial both for insertion and for ascertaining the correct placement of central venous lines.

The azygos vein has a much smaller lumen than the superior vena cava. Although the lumen size may vary significantly, the maximum diameter of the anterior arch of the azygos vein is about 6 to 7 mm,11 whereas the superior vena cava lumen is typically 1.5 to 2 cm in diameter.12 In addition, when a catheter is inserted into the superior vena cava, the direction of blood flow and the direction of the infusion are the same, but when the catheter is inserted into the azygos system, the directions of blood flow and infusion are opposite, contributing to local turbulence.

Both these factors increase the chance of puncturing the vein when the azygos arch is aberrantly cannulated for central venous access.9 Venous perforation has been reported in as many as 19% of cases in which the azygos arch was inadvertently cannulated. Venous perforation can lead to hemopericardium, hemomediastinum, and hemorrhagic pleural effusions, which can lead to significant morbidity and even death. Perforation, thrombosis, stenosis, and complete occlusion have been reported subsequent to catheter malposition in the azygos vein.13

Patients in whom the azygos vein is inadvertently cannulated may tolerate infusions and blood draws, but this does not mean that inadvertent azygos vein cannulation is acceptable, especially given the late complications of vascular perforation that can occur.9

The cannulation of the azygos vein in our patient was completely unintentional; nevertheless, the line was kept in and used for a short period for the initial rehydration and pain control and was subsequently removed without any complications.

WHEN IS CANNULATION OF THE AZYGOS VEIN AN OPTION?

In patients with previous multiple central vein cannulations, the rates of thrombosis and of fibrotic changes in these veins are high. In patients with thrombosis of both the superior vena cava and the inferior vena cava, direct insertion of a catheter into the azygos vein has been suggested as an alternate route to obtain access for dialysis.8 This approach has also been used successfully to administer total parenteral nutrition for a prolonged time in pediatric patients.14 In short, the azygos vein is never preferred for central venous access, but it can occasionally serve as an alternate route.5–9

TAKE-HOME POINTS

The radiographic assessment of an internal jugular or subclavian line may occasionally be deceptive if based solely on the anteroposterior view; confirmation may require a lateral view. We found no guidelines for using the azygos vein for central venous access. The options in cases of aberrant cannulation include leaving the line in, removing and reinserting it at the same or another site under fluoroscopy, and attempting to reposition it after changing the catheter over a guidewire.

The use of central lines found to be in an aberrant position should be driven by clinical judgment based on the urgency of the need of access, the availability or feasibility of other access options, and the intended use. The use of the azygos vein is fraught with procedural complications, as well as postprocedural complications related to vascular perforation. If the position of the catheter tip on the anteroposterior radiographic view is not satisfactory, obtaining a lateral view should be considered.

References
  1. McGee DC, Goud MK. Preventing complications of central venous catheterization. N Engl J Med. 2003; 348:11231133.
  2. Pittiruti M, Malerba M, Carriero C, Tazza L, Gui D. Which is the easiest and safest technique for central venous access? A retrospective survey of more than 5,400 cases. J Vasc Access. 2000; 1:100107.
  3. Towers MJ. Preventing complications of central venous catheterization. N Engl J Med 2003; 348:26842686; author reply 2684–2686.
  4. Langston CS. The aberrant central venous catheter and its complications. Radiology. 1971; 100:5559.
  5. Smith DC, Pop PM. Malposition of a total parenteral nutrition catheter in the accessory hemiazygos vein. JPEN J Parenter Enteral Nutr. 1983; 7:289292.
  6. Abood GJ, Davis KA, Esposito TJ, Luchette FA, Gamelli RL. Comparison of routine chest radiograph versus clinician judgment to determine adequate central line placement in critically ill patients. J Trauma. 2007; 63:5056.
  7. Gladwin MT, Slonim A, Landucci DL, Gutierrez DC, Cunnion RE. Cannulation of the internal jugular vein: is postprocedural chest radiography always necessary? Crit Care Med 1999; 27:18191823.
  8. Meranze SG, McLean GK, Stein EJ, Jordan HA. Catheter placement in the azygos system: an unusual approach to venous access. Am J Roentgenol. 1985; 144:10751076.
  9. Bankier AA, Mallek R, Wiesmayr MN, et al. Azygos arch cannulation by central venous catheters: radiographic detection of malposition and subsequent complications. J Thorac Imaging. 1997; 12:6469.
  10. Langston CT. The aberrant central venous catheter and its complications. Radiology. 1971; 100:5559.
  11. Heitzman ER. Radiologic appearance of the azygos vein in cardiovascular disease. Circulation. 1973; 47:628634.
  12. McGowan AR, Pugatch RD. Partial obstruction of the superior vena cava. BrighamRAD. Available at: http://brighamrad.harvard.edu/Cases/bwh/hcache/58/full.html. Accessed 9/4/2008.
  13. Granata A, Figuera M, Castellino S, Logias F, Basile A. Azygos arch cannulation by central venous catheters for hemodialysis. J Vasc Access. 2006; 7:4345.
  14. Malt RA, Kempster M. Direct azygos vein and superior vena cava cannulation for parenteral nutrition. JPEN J Parenter Enteral Nutr. 1983; 7:580581.
Article PDF
Author and Disclosure Information

Deepak Asudani, MD
Assistant Clinical Professor of Medicine, Tufts University School of Medicine–Baystate Medical Center, Springfield, MA

Sharon Wretzel, MD
Baystate Medical Center, Tufts University School of Medicine, Springfield, MA

Ruchita Patel, MD
Beverly Hospital and Addison Gilbert Hospital, Beverly, MA

Aaron Stayman, MD
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN

Address: Deepak Asudani, MD, Baystate Medical Center, Tufts University School of Medicine, 759 Chestnut Street, Springfield, MA 01199; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 75(10)
Publications
Topics
Page Number
690-691, 695
Sections
Author and Disclosure Information

Deepak Asudani, MD
Assistant Clinical Professor of Medicine, Tufts University School of Medicine–Baystate Medical Center, Springfield, MA

Sharon Wretzel, MD
Baystate Medical Center, Tufts University School of Medicine, Springfield, MA

Ruchita Patel, MD
Beverly Hospital and Addison Gilbert Hospital, Beverly, MA

Aaron Stayman, MD
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN

Address: Deepak Asudani, MD, Baystate Medical Center, Tufts University School of Medicine, 759 Chestnut Street, Springfield, MA 01199; e-mail [email protected]

Author and Disclosure Information

Deepak Asudani, MD
Assistant Clinical Professor of Medicine, Tufts University School of Medicine–Baystate Medical Center, Springfield, MA

Sharon Wretzel, MD
Baystate Medical Center, Tufts University School of Medicine, Springfield, MA

Ruchita Patel, MD
Beverly Hospital and Addison Gilbert Hospital, Beverly, MA

Aaron Stayman, MD
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN

Address: Deepak Asudani, MD, Baystate Medical Center, Tufts University School of Medicine, 759 Chestnut Street, Springfield, MA 01199; e-mail [email protected]

Article PDF
Article PDF

A 22-year-old African American man with sickle cell disease comes to the in his joints and chest—a presentation similar to those of his previous sickle cell crises. He is given intravenous fluids for dehydration and morphine sulfate for pain via a peripheral line, and he is admitted to the hospital.

Shortly afterward, the peripheral line becomes infiltrated. After failed attempts at peripheral cannulation, central venous cannulation via an internal jugular site is considered.

Figure 1.
The patient alerts us that he has had multiple “neck lines” in the past and that these had been difficult to place. With this in mind, we attempt to place a triple-lumen catheter under ultrasonographic guidance and with the use of sterile precautions and the Seldinger technique. On the first attempt, the guidewire cannot be advanced beyond 4 cm, and the attempt is terminated. On the second attempt, the guidewire advances freely, but as the catheter is advanced, slight resistance is felt at 4 cm and again at 10 cm. This resistance is overcome with slight pressure, and subsequent advancement meets with no further resistance. After confirming nonpulsatile blood return in all three lumens, we suture the catheter at 14 cm from the insertion site. A chest radiograph (Figure 1) is requested to confirm placement.

WHERE IS THE CATHETER TIP?

Figure 2.
At first look, the catheter appears to broadly follow an expected trajectory. However, a closer look shows that the catheter is not properly positioned: although it is difficult to see, the tip appears to project beyond the main carina (see arrow), an important landmark to identify catheter tip placement. It appears to go beyond the expected site of the junction of the superior vena cava and the right atrium. Also, at the level of the right main-stem bronchus, the catheter appears to curve with an infero-lateral convexity. To confirm the placement, a lateral view is obtained (Figure 2). As evident in this view, the internal jugular catheter does not terminate at the desirable level, but rather turns posteriorly to extend into the azygos vein (see arrow). The lateral view was required in this patient to ascertain the exact location of the catheter tip.

HAZARDS OF ABERRANT LINE PLACEMENT

Central venous catheters are commonly used to give various infusions (eg, parenteral nutrition), to draw blood, and to monitor the central venous pressure.1 The internal jugular vein is one of the preferred veins for central venous access.1,2 Normally, the anatomy of the jugular venous system and the design of the catheter facilitate proper insertion. Occasionally, however, despite proper technique, the tip of the catheter may not terminate at the desired level, resulting in aberrant placement in the internal thoracic vein, superior vena cava, azygos vein, accessory hemiazygos vein, or axillary vein.1–8

The use of chest radiographs to establish the correct placement of internal jugular and subclavian lines has been advocated and is routinely practiced.6,7 Obtaining a chest x-ray to confirm line placement is particularly important in patients with prior multiple and difficult catheterizations. The lateral view is seldom obtained when confirming central neck line placement, but when the anteroposterior view is not reassuring, it may be prudent to obtain this alternate view.

In a large retrospective analysis,9 cannulation of the azygos arch occurred in about 1.2% of insertions, and the rate was about seven times higher when the left jugular vein was used than when the right one was used. A smaller study gave the frequency of azygos arch cannulation as 0.7%.10

All procedure-related complications of central line insertion in the neck can also occur with aberrant azygos vein cannulation. These include infection, bacteremia, pneumothorax, hemothorax, arterial puncture, and various other mechanical complications. It should be noted that aberrant cannulation of the azygos arch is particularly hazardous, and that complication rates are typically higher. These complications are mainly due to the smaller vascular lumen and to the direction of blood flow in the azygos venous system.

 

 

KNOWING THE ANATOMY IS CRUCIAL

Knowledge of venous anatomy and its variants is crucial both for insertion and for ascertaining the correct placement of central venous lines.

The azygos vein has a much smaller lumen than the superior vena cava. Although the lumen size may vary significantly, the maximum diameter of the anterior arch of the azygos vein is about 6 to 7 mm,11 whereas the superior vena cava lumen is typically 1.5 to 2 cm in diameter.12 In addition, when a catheter is inserted into the superior vena cava, the direction of blood flow and the direction of the infusion are the same, but when the catheter is inserted into the azygos system, the directions of blood flow and infusion are opposite, contributing to local turbulence.

Both these factors increase the chance of puncturing the vein when the azygos arch is aberrantly cannulated for central venous access.9 Venous perforation has been reported in as many as 19% of cases in which the azygos arch was inadvertently cannulated. Venous perforation can lead to hemopericardium, hemomediastinum, and hemorrhagic pleural effusions, which can lead to significant morbidity and even death. Perforation, thrombosis, stenosis, and complete occlusion have been reported subsequent to catheter malposition in the azygos vein.13

Patients in whom the azygos vein is inadvertently cannulated may tolerate infusions and blood draws, but this does not mean that inadvertent azygos vein cannulation is acceptable, especially given the late complications of vascular perforation that can occur.9

The cannulation of the azygos vein in our patient was completely unintentional; nevertheless, the line was kept in and used for a short period for the initial rehydration and pain control and was subsequently removed without any complications.

WHEN IS CANNULATION OF THE AZYGOS VEIN AN OPTION?

In patients with previous multiple central vein cannulations, the rates of thrombosis and of fibrotic changes in these veins are high. In patients with thrombosis of both the superior vena cava and the inferior vena cava, direct insertion of a catheter into the azygos vein has been suggested as an alternate route to obtain access for dialysis.8 This approach has also been used successfully to administer total parenteral nutrition for a prolonged time in pediatric patients.14 In short, the azygos vein is never preferred for central venous access, but it can occasionally serve as an alternate route.5–9

TAKE-HOME POINTS

The radiographic assessment of an internal jugular or subclavian line may occasionally be deceptive if based solely on the anteroposterior view; confirmation may require a lateral view. We found no guidelines for using the azygos vein for central venous access. The options in cases of aberrant cannulation include leaving the line in, removing and reinserting it at the same or another site under fluoroscopy, and attempting to reposition it after changing the catheter over a guidewire.

The use of central lines found to be in an aberrant position should be driven by clinical judgment based on the urgency of the need of access, the availability or feasibility of other access options, and the intended use. The use of the azygos vein is fraught with procedural complications, as well as postprocedural complications related to vascular perforation. If the position of the catheter tip on the anteroposterior radiographic view is not satisfactory, obtaining a lateral view should be considered.

A 22-year-old African American man with sickle cell disease comes to the in his joints and chest—a presentation similar to those of his previous sickle cell crises. He is given intravenous fluids for dehydration and morphine sulfate for pain via a peripheral line, and he is admitted to the hospital.

Shortly afterward, the peripheral line becomes infiltrated. After failed attempts at peripheral cannulation, central venous cannulation via an internal jugular site is considered.

Figure 1.
The patient alerts us that he has had multiple “neck lines” in the past and that these had been difficult to place. With this in mind, we attempt to place a triple-lumen catheter under ultrasonographic guidance and with the use of sterile precautions and the Seldinger technique. On the first attempt, the guidewire cannot be advanced beyond 4 cm, and the attempt is terminated. On the second attempt, the guidewire advances freely, but as the catheter is advanced, slight resistance is felt at 4 cm and again at 10 cm. This resistance is overcome with slight pressure, and subsequent advancement meets with no further resistance. After confirming nonpulsatile blood return in all three lumens, we suture the catheter at 14 cm from the insertion site. A chest radiograph (Figure 1) is requested to confirm placement.

WHERE IS THE CATHETER TIP?

Figure 2.
At first look, the catheter appears to broadly follow an expected trajectory. However, a closer look shows that the catheter is not properly positioned: although it is difficult to see, the tip appears to project beyond the main carina (see arrow), an important landmark to identify catheter tip placement. It appears to go beyond the expected site of the junction of the superior vena cava and the right atrium. Also, at the level of the right main-stem bronchus, the catheter appears to curve with an infero-lateral convexity. To confirm the placement, a lateral view is obtained (Figure 2). As evident in this view, the internal jugular catheter does not terminate at the desirable level, but rather turns posteriorly to extend into the azygos vein (see arrow). The lateral view was required in this patient to ascertain the exact location of the catheter tip.

HAZARDS OF ABERRANT LINE PLACEMENT

Central venous catheters are commonly used to give various infusions (eg, parenteral nutrition), to draw blood, and to monitor the central venous pressure.1 The internal jugular vein is one of the preferred veins for central venous access.1,2 Normally, the anatomy of the jugular venous system and the design of the catheter facilitate proper insertion. Occasionally, however, despite proper technique, the tip of the catheter may not terminate at the desired level, resulting in aberrant placement in the internal thoracic vein, superior vena cava, azygos vein, accessory hemiazygos vein, or axillary vein.1–8

The use of chest radiographs to establish the correct placement of internal jugular and subclavian lines has been advocated and is routinely practiced.6,7 Obtaining a chest x-ray to confirm line placement is particularly important in patients with prior multiple and difficult catheterizations. The lateral view is seldom obtained when confirming central neck line placement, but when the anteroposterior view is not reassuring, it may be prudent to obtain this alternate view.

In a large retrospective analysis,9 cannulation of the azygos arch occurred in about 1.2% of insertions, and the rate was about seven times higher when the left jugular vein was used than when the right one was used. A smaller study gave the frequency of azygos arch cannulation as 0.7%.10

All procedure-related complications of central line insertion in the neck can also occur with aberrant azygos vein cannulation. These include infection, bacteremia, pneumothorax, hemothorax, arterial puncture, and various other mechanical complications. It should be noted that aberrant cannulation of the azygos arch is particularly hazardous, and that complication rates are typically higher. These complications are mainly due to the smaller vascular lumen and to the direction of blood flow in the azygos venous system.

 

 

KNOWING THE ANATOMY IS CRUCIAL

Knowledge of venous anatomy and its variants is crucial both for insertion and for ascertaining the correct placement of central venous lines.

The azygos vein has a much smaller lumen than the superior vena cava. Although the lumen size may vary significantly, the maximum diameter of the anterior arch of the azygos vein is about 6 to 7 mm,11 whereas the superior vena cava lumen is typically 1.5 to 2 cm in diameter.12 In addition, when a catheter is inserted into the superior vena cava, the direction of blood flow and the direction of the infusion are the same, but when the catheter is inserted into the azygos system, the directions of blood flow and infusion are opposite, contributing to local turbulence.

Both these factors increase the chance of puncturing the vein when the azygos arch is aberrantly cannulated for central venous access.9 Venous perforation has been reported in as many as 19% of cases in which the azygos arch was inadvertently cannulated. Venous perforation can lead to hemopericardium, hemomediastinum, and hemorrhagic pleural effusions, which can lead to significant morbidity and even death. Perforation, thrombosis, stenosis, and complete occlusion have been reported subsequent to catheter malposition in the azygos vein.13

Patients in whom the azygos vein is inadvertently cannulated may tolerate infusions and blood draws, but this does not mean that inadvertent azygos vein cannulation is acceptable, especially given the late complications of vascular perforation that can occur.9

The cannulation of the azygos vein in our patient was completely unintentional; nevertheless, the line was kept in and used for a short period for the initial rehydration and pain control and was subsequently removed without any complications.

WHEN IS CANNULATION OF THE AZYGOS VEIN AN OPTION?

In patients with previous multiple central vein cannulations, the rates of thrombosis and of fibrotic changes in these veins are high. In patients with thrombosis of both the superior vena cava and the inferior vena cava, direct insertion of a catheter into the azygos vein has been suggested as an alternate route to obtain access for dialysis.8 This approach has also been used successfully to administer total parenteral nutrition for a prolonged time in pediatric patients.14 In short, the azygos vein is never preferred for central venous access, but it can occasionally serve as an alternate route.5–9

TAKE-HOME POINTS

The radiographic assessment of an internal jugular or subclavian line may occasionally be deceptive if based solely on the anteroposterior view; confirmation may require a lateral view. We found no guidelines for using the azygos vein for central venous access. The options in cases of aberrant cannulation include leaving the line in, removing and reinserting it at the same or another site under fluoroscopy, and attempting to reposition it after changing the catheter over a guidewire.

The use of central lines found to be in an aberrant position should be driven by clinical judgment based on the urgency of the need of access, the availability or feasibility of other access options, and the intended use. The use of the azygos vein is fraught with procedural complications, as well as postprocedural complications related to vascular perforation. If the position of the catheter tip on the anteroposterior radiographic view is not satisfactory, obtaining a lateral view should be considered.

References
  1. McGee DC, Goud MK. Preventing complications of central venous catheterization. N Engl J Med. 2003; 348:11231133.
  2. Pittiruti M, Malerba M, Carriero C, Tazza L, Gui D. Which is the easiest and safest technique for central venous access? A retrospective survey of more than 5,400 cases. J Vasc Access. 2000; 1:100107.
  3. Towers MJ. Preventing complications of central venous catheterization. N Engl J Med 2003; 348:26842686; author reply 2684–2686.
  4. Langston CS. The aberrant central venous catheter and its complications. Radiology. 1971; 100:5559.
  5. Smith DC, Pop PM. Malposition of a total parenteral nutrition catheter in the accessory hemiazygos vein. JPEN J Parenter Enteral Nutr. 1983; 7:289292.
  6. Abood GJ, Davis KA, Esposito TJ, Luchette FA, Gamelli RL. Comparison of routine chest radiograph versus clinician judgment to determine adequate central line placement in critically ill patients. J Trauma. 2007; 63:5056.
  7. Gladwin MT, Slonim A, Landucci DL, Gutierrez DC, Cunnion RE. Cannulation of the internal jugular vein: is postprocedural chest radiography always necessary? Crit Care Med 1999; 27:18191823.
  8. Meranze SG, McLean GK, Stein EJ, Jordan HA. Catheter placement in the azygos system: an unusual approach to venous access. Am J Roentgenol. 1985; 144:10751076.
  9. Bankier AA, Mallek R, Wiesmayr MN, et al. Azygos arch cannulation by central venous catheters: radiographic detection of malposition and subsequent complications. J Thorac Imaging. 1997; 12:6469.
  10. Langston CT. The aberrant central venous catheter and its complications. Radiology. 1971; 100:5559.
  11. Heitzman ER. Radiologic appearance of the azygos vein in cardiovascular disease. Circulation. 1973; 47:628634.
  12. McGowan AR, Pugatch RD. Partial obstruction of the superior vena cava. BrighamRAD. Available at: http://brighamrad.harvard.edu/Cases/bwh/hcache/58/full.html. Accessed 9/4/2008.
  13. Granata A, Figuera M, Castellino S, Logias F, Basile A. Azygos arch cannulation by central venous catheters for hemodialysis. J Vasc Access. 2006; 7:4345.
  14. Malt RA, Kempster M. Direct azygos vein and superior vena cava cannulation for parenteral nutrition. JPEN J Parenter Enteral Nutr. 1983; 7:580581.
References
  1. McGee DC, Goud MK. Preventing complications of central venous catheterization. N Engl J Med. 2003; 348:11231133.
  2. Pittiruti M, Malerba M, Carriero C, Tazza L, Gui D. Which is the easiest and safest technique for central venous access? A retrospective survey of more than 5,400 cases. J Vasc Access. 2000; 1:100107.
  3. Towers MJ. Preventing complications of central venous catheterization. N Engl J Med 2003; 348:26842686; author reply 2684–2686.
  4. Langston CS. The aberrant central venous catheter and its complications. Radiology. 1971; 100:5559.
  5. Smith DC, Pop PM. Malposition of a total parenteral nutrition catheter in the accessory hemiazygos vein. JPEN J Parenter Enteral Nutr. 1983; 7:289292.
  6. Abood GJ, Davis KA, Esposito TJ, Luchette FA, Gamelli RL. Comparison of routine chest radiograph versus clinician judgment to determine adequate central line placement in critically ill patients. J Trauma. 2007; 63:5056.
  7. Gladwin MT, Slonim A, Landucci DL, Gutierrez DC, Cunnion RE. Cannulation of the internal jugular vein: is postprocedural chest radiography always necessary? Crit Care Med 1999; 27:18191823.
  8. Meranze SG, McLean GK, Stein EJ, Jordan HA. Catheter placement in the azygos system: an unusual approach to venous access. Am J Roentgenol. 1985; 144:10751076.
  9. Bankier AA, Mallek R, Wiesmayr MN, et al. Azygos arch cannulation by central venous catheters: radiographic detection of malposition and subsequent complications. J Thorac Imaging. 1997; 12:6469.
  10. Langston CT. The aberrant central venous catheter and its complications. Radiology. 1971; 100:5559.
  11. Heitzman ER. Radiologic appearance of the azygos vein in cardiovascular disease. Circulation. 1973; 47:628634.
  12. McGowan AR, Pugatch RD. Partial obstruction of the superior vena cava. BrighamRAD. Available at: http://brighamrad.harvard.edu/Cases/bwh/hcache/58/full.html. Accessed 9/4/2008.
  13. Granata A, Figuera M, Castellino S, Logias F, Basile A. Azygos arch cannulation by central venous catheters for hemodialysis. J Vasc Access. 2006; 7:4345.
  14. Malt RA, Kempster M. Direct azygos vein and superior vena cava cannulation for parenteral nutrition. JPEN J Parenter Enteral Nutr. 1983; 7:580581.
Issue
Cleveland Clinic Journal of Medicine - 75(10)
Issue
Cleveland Clinic Journal of Medicine - 75(10)
Page Number
690-691, 695
Page Number
690-691, 695
Publications
Publications
Topics
Article Type
Display Headline
A judgment call
Display Headline
A judgment call
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Left Heart Shape and Size Are Risk Indicators in Elderly

Article Type
Changed
Display Headline
Left Heart Shape and Size Are Risk Indicators in Elderly

TORONTO — Increased left-atrial volume and abnormal left-ventricular geometry were each independent predictors of death in elderly patients with preserved systolic heart function in a large study.

The findings suggest a potential role for left-atrial volume index and assessment of left-ventricular geometry when evaluating elderly patients, Dr. Dharmendrakumar A. Patel said at the 14th World Congress on Heart Disease. Both parameters are measured by echocardiography.

A high left-atrial volume index may be an indicator of diastolic dysfunction, said Dr. Patel, a researcher at the Ochsner Clinic in New Orleans. But as of today, no interventions have proved to reduce left-atrial volume and thereby improve prognosis.

His study used echo results from 11,039 patients older than 70 years (average age 78 years) who were referred for an echocardiographic examination at the Ochsner Clinic in 2004-2006. All patients had a left-ventricular ejection fraction of at least 50%, and their average ejection fraction was about 60%. In an average follow-up of 1.6 years, 1,531 patients (14%) died.

Analysis of mortality by left-atrial volume index showed that the patients in the quartile with the largest left atria had a 19% mortality rate, significantly higher than the 11% death rate in the patients in the quartile with the smallest left atria. The average left-atrial volume index was 32.5 mL/m

Patients with abnormal left-ventricular geometry also had worse survival, compared with those with normal geometry. The mortality rate during follow-up was 12% in those with normal left-ventricular geometry at baseline (about 50% of all participants), compared with 19% mortality in the 5% of patients with concentric, left-ventricular hypertrophy at baseline, the geometry that carried the highest mortality risk. Patients with concentric remodeling and those with eccentric hypertrophy also had significantly increased death rates, about 15%-16%, during follow-up.

Multivariate analysis showed that left-atrial volume index and abnormal left-ventricular geometry were significant, independent factors contributing to mortality. Other significant determinants were age, sex, BMI, and LVEF.

An additional analysis showed that of the quartile of patients with the highest left-atrial volume index, those who also had a left ventricle with a concentric, hypertrophic shape had a strikingly high 50% mortality rate during follow-up.

A limitation of this study was that it included only people who had been referred for cardiac echocardiography. Dr. Patel also did not have information on causes of death or the prevalence of comorbidities.

A high left-atrial volume index may be an indicator of diastolic dysfunction. But there is no current treatment for it. DR. PATEL

In elderly patients with preserved systolic heart function, left-atrial volume, shown in four-chamber (left) and two-chamber apical (right) views, predicted death. Abnormal left-ventricular geometry was also found to be a predictor. Braunwald's Heart Disease, A Textbook of Cardiovascular Medicine, 8th ed., Chapter 14, ©Elsevier (2008)

Article PDF
Author and Disclosure Information

Publications
Topics
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

TORONTO — Increased left-atrial volume and abnormal left-ventricular geometry were each independent predictors of death in elderly patients with preserved systolic heart function in a large study.

The findings suggest a potential role for left-atrial volume index and assessment of left-ventricular geometry when evaluating elderly patients, Dr. Dharmendrakumar A. Patel said at the 14th World Congress on Heart Disease. Both parameters are measured by echocardiography.

A high left-atrial volume index may be an indicator of diastolic dysfunction, said Dr. Patel, a researcher at the Ochsner Clinic in New Orleans. But as of today, no interventions have proved to reduce left-atrial volume and thereby improve prognosis.

His study used echo results from 11,039 patients older than 70 years (average age 78 years) who were referred for an echocardiographic examination at the Ochsner Clinic in 2004-2006. All patients had a left-ventricular ejection fraction of at least 50%, and their average ejection fraction was about 60%. In an average follow-up of 1.6 years, 1,531 patients (14%) died.

Analysis of mortality by left-atrial volume index showed that the patients in the quartile with the largest left atria had a 19% mortality rate, significantly higher than the 11% death rate in the patients in the quartile with the smallest left atria. The average left-atrial volume index was 32.5 mL/m

Patients with abnormal left-ventricular geometry also had worse survival, compared with those with normal geometry. The mortality rate during follow-up was 12% in those with normal left-ventricular geometry at baseline (about 50% of all participants), compared with 19% mortality in the 5% of patients with concentric, left-ventricular hypertrophy at baseline, the geometry that carried the highest mortality risk. Patients with concentric remodeling and those with eccentric hypertrophy also had significantly increased death rates, about 15%-16%, during follow-up.

Multivariate analysis showed that left-atrial volume index and abnormal left-ventricular geometry were significant, independent factors contributing to mortality. Other significant determinants were age, sex, BMI, and LVEF.

An additional analysis showed that of the quartile of patients with the highest left-atrial volume index, those who also had a left ventricle with a concentric, hypertrophic shape had a strikingly high 50% mortality rate during follow-up.

A limitation of this study was that it included only people who had been referred for cardiac echocardiography. Dr. Patel also did not have information on causes of death or the prevalence of comorbidities.

A high left-atrial volume index may be an indicator of diastolic dysfunction. But there is no current treatment for it. DR. PATEL

In elderly patients with preserved systolic heart function, left-atrial volume, shown in four-chamber (left) and two-chamber apical (right) views, predicted death. Abnormal left-ventricular geometry was also found to be a predictor. Braunwald's Heart Disease, A Textbook of Cardiovascular Medicine, 8th ed., Chapter 14, ©Elsevier (2008)

TORONTO — Increased left-atrial volume and abnormal left-ventricular geometry were each independent predictors of death in elderly patients with preserved systolic heart function in a large study.

The findings suggest a potential role for left-atrial volume index and assessment of left-ventricular geometry when evaluating elderly patients, Dr. Dharmendrakumar A. Patel said at the 14th World Congress on Heart Disease. Both parameters are measured by echocardiography.

A high left-atrial volume index may be an indicator of diastolic dysfunction, said Dr. Patel, a researcher at the Ochsner Clinic in New Orleans. But as of today, no interventions have proved to reduce left-atrial volume and thereby improve prognosis.

His study used echo results from 11,039 patients older than 70 years (average age 78 years) who were referred for an echocardiographic examination at the Ochsner Clinic in 2004-2006. All patients had a left-ventricular ejection fraction of at least 50%, and their average ejection fraction was about 60%. In an average follow-up of 1.6 years, 1,531 patients (14%) died.

Analysis of mortality by left-atrial volume index showed that the patients in the quartile with the largest left atria had a 19% mortality rate, significantly higher than the 11% death rate in the patients in the quartile with the smallest left atria. The average left-atrial volume index was 32.5 mL/m

Patients with abnormal left-ventricular geometry also had worse survival, compared with those with normal geometry. The mortality rate during follow-up was 12% in those with normal left-ventricular geometry at baseline (about 50% of all participants), compared with 19% mortality in the 5% of patients with concentric, left-ventricular hypertrophy at baseline, the geometry that carried the highest mortality risk. Patients with concentric remodeling and those with eccentric hypertrophy also had significantly increased death rates, about 15%-16%, during follow-up.

Multivariate analysis showed that left-atrial volume index and abnormal left-ventricular geometry were significant, independent factors contributing to mortality. Other significant determinants were age, sex, BMI, and LVEF.

An additional analysis showed that of the quartile of patients with the highest left-atrial volume index, those who also had a left ventricle with a concentric, hypertrophic shape had a strikingly high 50% mortality rate during follow-up.

A limitation of this study was that it included only people who had been referred for cardiac echocardiography. Dr. Patel also did not have information on causes of death or the prevalence of comorbidities.

A high left-atrial volume index may be an indicator of diastolic dysfunction. But there is no current treatment for it. DR. PATEL

In elderly patients with preserved systolic heart function, left-atrial volume, shown in four-chamber (left) and two-chamber apical (right) views, predicted death. Abnormal left-ventricular geometry was also found to be a predictor. Braunwald's Heart Disease, A Textbook of Cardiovascular Medicine, 8th ed., Chapter 14, ©Elsevier (2008)

Publications
Publications
Topics
Article Type
Display Headline
Left Heart Shape and Size Are Risk Indicators in Elderly
Display Headline
Left Heart Shape and Size Are Risk Indicators in Elderly
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

MPI SPECT Screening in Diabetes Unjustified

Article Type
Changed
Display Headline
MPI SPECT Screening in Diabetes Unjustified

BOSTON — Screening asymptomatic diabetes patients for myocardial ischemia using advanced imaging does not improve their 5-year prognosis for coronary events, compared with standard care, study results have shown.

In addition to this “unexpected” finding from the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study, a surprisingly low rate of ischemia was uncovered by the screening protocol in this population of patients who are considered to be at high risk for coronary disease, Dr. Frans J. Wackers reported at the annual meeting of the American Society of Nuclear Cardiology.

Of 561 type 2 diabetes patients without symptomatic or previously diagnosed coronary artery disease who underwent screening with stress adenosine myocardial perfusion imaging (MPI) as part of the study, “only 22% had inducible ischemia, which was far less than we expected,” said Dr. Wackers of Yale University, New Haven, Conn.

During a mean follow-up of 4.8 years, there was no difference in the rates of cardiac events between patients in the screening group and the 562 patients in the standard care control group, he said, noting that the cumulative rate of cardiac events for both groups was approximately 3%.

The goal of the DIAD study was to determine the prevalence of silent myocardial ischemia in adults with type 2 diabetes without evidence of coronary artery disease, as well as the cost-effectiveness of screening all diabetes patients for ischemia using MPI single-photon emission computed tomography (SPECT).

The multicenter study randomized 1,123 patients, aged 55-75 years, with a mean diabetes duration of 8.7 years to MPI SPECT screening or to standard care without screening. Subsequent diagnostic testing in both groups was performed at the discretion of patients' primary caregivers, even among those patients identified as having silent myocardial ischemia.

“When we gave the results to the physicians, we did not recommend treatment or referral to cardiologists because we didn't know if the results were [clinically relevant],” said Dr. Wackers.

All of the patients in the study were called at 6-month intervals to assess their cardiovascular health and treatment status.

In both the screening and standard care groups, 7% of the patients underwent coronary artery bypass grafting surgery during the course of the study. Additionally, the use of aspirin, statin drugs, and angiotensin-converting enzyme inhibitors increased significantly over the 5-year period, which probably explains why patients in both groups did so well, Dr. Wackers said.

With respect to the imaging findings in the screened population, patients with normal MPI results or with small MPI defects had 5-year cumulative cardiac event rates of 2.1% and 2.0%, respectively.

However, the cumulative cardiac event rates among patients who had moderate to large MPI defects, as well as those found to have nonperfusion abnormalities such as ischemic changes on electrocardiogram, were significantly higher, at 12.3% and 6.8%, respectively, Dr. Wackers reported.

In addition to moderate/large MPI defects and nonperfusion abnormalities, the investigators found that predictors of cardiac events by Cox regression included male sex, peripheral vascular disease, creatinine level, and abnormal heart rate response to standing.

The findings indicate that clinical events and significant inducible ischemia both identify higher-risk patients with type 2 diabetes, “but overall rates of cardiac events are equivalent whether or not patients undergo initial screening,” Dr. Wackers stated.

Dr. Wackers reported no financial conflicts of interest related to this presentation.

'Overall rates of cardiac events are equivalent whether or not patients undergo initial screening.' DR. WACKERS

Article PDF
Author and Disclosure Information

Publications
Topics
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

BOSTON — Screening asymptomatic diabetes patients for myocardial ischemia using advanced imaging does not improve their 5-year prognosis for coronary events, compared with standard care, study results have shown.

In addition to this “unexpected” finding from the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study, a surprisingly low rate of ischemia was uncovered by the screening protocol in this population of patients who are considered to be at high risk for coronary disease, Dr. Frans J. Wackers reported at the annual meeting of the American Society of Nuclear Cardiology.

Of 561 type 2 diabetes patients without symptomatic or previously diagnosed coronary artery disease who underwent screening with stress adenosine myocardial perfusion imaging (MPI) as part of the study, “only 22% had inducible ischemia, which was far less than we expected,” said Dr. Wackers of Yale University, New Haven, Conn.

During a mean follow-up of 4.8 years, there was no difference in the rates of cardiac events between patients in the screening group and the 562 patients in the standard care control group, he said, noting that the cumulative rate of cardiac events for both groups was approximately 3%.

The goal of the DIAD study was to determine the prevalence of silent myocardial ischemia in adults with type 2 diabetes without evidence of coronary artery disease, as well as the cost-effectiveness of screening all diabetes patients for ischemia using MPI single-photon emission computed tomography (SPECT).

The multicenter study randomized 1,123 patients, aged 55-75 years, with a mean diabetes duration of 8.7 years to MPI SPECT screening or to standard care without screening. Subsequent diagnostic testing in both groups was performed at the discretion of patients' primary caregivers, even among those patients identified as having silent myocardial ischemia.

“When we gave the results to the physicians, we did not recommend treatment or referral to cardiologists because we didn't know if the results were [clinically relevant],” said Dr. Wackers.

All of the patients in the study were called at 6-month intervals to assess their cardiovascular health and treatment status.

In both the screening and standard care groups, 7% of the patients underwent coronary artery bypass grafting surgery during the course of the study. Additionally, the use of aspirin, statin drugs, and angiotensin-converting enzyme inhibitors increased significantly over the 5-year period, which probably explains why patients in both groups did so well, Dr. Wackers said.

With respect to the imaging findings in the screened population, patients with normal MPI results or with small MPI defects had 5-year cumulative cardiac event rates of 2.1% and 2.0%, respectively.

However, the cumulative cardiac event rates among patients who had moderate to large MPI defects, as well as those found to have nonperfusion abnormalities such as ischemic changes on electrocardiogram, were significantly higher, at 12.3% and 6.8%, respectively, Dr. Wackers reported.

In addition to moderate/large MPI defects and nonperfusion abnormalities, the investigators found that predictors of cardiac events by Cox regression included male sex, peripheral vascular disease, creatinine level, and abnormal heart rate response to standing.

The findings indicate that clinical events and significant inducible ischemia both identify higher-risk patients with type 2 diabetes, “but overall rates of cardiac events are equivalent whether or not patients undergo initial screening,” Dr. Wackers stated.

Dr. Wackers reported no financial conflicts of interest related to this presentation.

'Overall rates of cardiac events are equivalent whether or not patients undergo initial screening.' DR. WACKERS

BOSTON — Screening asymptomatic diabetes patients for myocardial ischemia using advanced imaging does not improve their 5-year prognosis for coronary events, compared with standard care, study results have shown.

In addition to this “unexpected” finding from the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study, a surprisingly low rate of ischemia was uncovered by the screening protocol in this population of patients who are considered to be at high risk for coronary disease, Dr. Frans J. Wackers reported at the annual meeting of the American Society of Nuclear Cardiology.

Of 561 type 2 diabetes patients without symptomatic or previously diagnosed coronary artery disease who underwent screening with stress adenosine myocardial perfusion imaging (MPI) as part of the study, “only 22% had inducible ischemia, which was far less than we expected,” said Dr. Wackers of Yale University, New Haven, Conn.

During a mean follow-up of 4.8 years, there was no difference in the rates of cardiac events between patients in the screening group and the 562 patients in the standard care control group, he said, noting that the cumulative rate of cardiac events for both groups was approximately 3%.

The goal of the DIAD study was to determine the prevalence of silent myocardial ischemia in adults with type 2 diabetes without evidence of coronary artery disease, as well as the cost-effectiveness of screening all diabetes patients for ischemia using MPI single-photon emission computed tomography (SPECT).

The multicenter study randomized 1,123 patients, aged 55-75 years, with a mean diabetes duration of 8.7 years to MPI SPECT screening or to standard care without screening. Subsequent diagnostic testing in both groups was performed at the discretion of patients' primary caregivers, even among those patients identified as having silent myocardial ischemia.

“When we gave the results to the physicians, we did not recommend treatment or referral to cardiologists because we didn't know if the results were [clinically relevant],” said Dr. Wackers.

All of the patients in the study were called at 6-month intervals to assess their cardiovascular health and treatment status.

In both the screening and standard care groups, 7% of the patients underwent coronary artery bypass grafting surgery during the course of the study. Additionally, the use of aspirin, statin drugs, and angiotensin-converting enzyme inhibitors increased significantly over the 5-year period, which probably explains why patients in both groups did so well, Dr. Wackers said.

With respect to the imaging findings in the screened population, patients with normal MPI results or with small MPI defects had 5-year cumulative cardiac event rates of 2.1% and 2.0%, respectively.

However, the cumulative cardiac event rates among patients who had moderate to large MPI defects, as well as those found to have nonperfusion abnormalities such as ischemic changes on electrocardiogram, were significantly higher, at 12.3% and 6.8%, respectively, Dr. Wackers reported.

In addition to moderate/large MPI defects and nonperfusion abnormalities, the investigators found that predictors of cardiac events by Cox regression included male sex, peripheral vascular disease, creatinine level, and abnormal heart rate response to standing.

The findings indicate that clinical events and significant inducible ischemia both identify higher-risk patients with type 2 diabetes, “but overall rates of cardiac events are equivalent whether or not patients undergo initial screening,” Dr. Wackers stated.

Dr. Wackers reported no financial conflicts of interest related to this presentation.

'Overall rates of cardiac events are equivalent whether or not patients undergo initial screening.' DR. WACKERS

Publications
Publications
Topics
Article Type
Display Headline
MPI SPECT Screening in Diabetes Unjustified
Display Headline
MPI SPECT Screening in Diabetes Unjustified
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Computer-Reconstructed Radiographs Are as Good as Plain Radiographs for Assessment of Acetabular Fractures

Article Type
Changed
Display Headline
Computer-Reconstructed Radiographs Are as Good as Plain Radiographs for Assessment of Acetabular Fractures

Article PDF
Author and Disclosure Information

Joseph Borrelli, Jr., MD, Michael Peelle, MD, Elizabeth McFarland, MD, Bradley Evanoff, MD, and William M. Ricci, MD

Dr. Borrelli is Professor and Chairman, Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.

Dr. Peelle is with the 88th Surgical Operations Squadron, Wright Patterson Air Force Base, Ohio.

Dr. McFarland is Associate Professor, Mallinckrodt Institute of Radiology, Dr. Evanoff is Associate Professor, Division of General Medical Sciences, Department of Medicine, and Dr. Ricci is Associate Professor, Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri.

Issue
The American Journal of Orthopedics - 37(9)
Publications
Topics
Page Number
455-460
Legacy Keywords
computer-reconstructed radiograph, CRR, plain, radiographs, acetabular, fractures, computed tomography, pushbroom, scanner, ajo, american journal of orthopedics
Sections
Author and Disclosure Information

Joseph Borrelli, Jr., MD, Michael Peelle, MD, Elizabeth McFarland, MD, Bradley Evanoff, MD, and William M. Ricci, MD

Dr. Borrelli is Professor and Chairman, Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.

Dr. Peelle is with the 88th Surgical Operations Squadron, Wright Patterson Air Force Base, Ohio.

Dr. McFarland is Associate Professor, Mallinckrodt Institute of Radiology, Dr. Evanoff is Associate Professor, Division of General Medical Sciences, Department of Medicine, and Dr. Ricci is Associate Professor, Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri.

Author and Disclosure Information

Joseph Borrelli, Jr., MD, Michael Peelle, MD, Elizabeth McFarland, MD, Bradley Evanoff, MD, and William M. Ricci, MD

Dr. Borrelli is Professor and Chairman, Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.

Dr. Peelle is with the 88th Surgical Operations Squadron, Wright Patterson Air Force Base, Ohio.

Dr. McFarland is Associate Professor, Mallinckrodt Institute of Radiology, Dr. Evanoff is Associate Professor, Division of General Medical Sciences, Department of Medicine, and Dr. Ricci is Associate Professor, Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri.

Article PDF
Article PDF

Issue
The American Journal of Orthopedics - 37(9)
Issue
The American Journal of Orthopedics - 37(9)
Page Number
455-460
Page Number
455-460
Publications
Publications
Topics
Article Type
Display Headline
Computer-Reconstructed Radiographs Are as Good as Plain Radiographs for Assessment of Acetabular Fractures
Display Headline
Computer-Reconstructed Radiographs Are as Good as Plain Radiographs for Assessment of Acetabular Fractures
Legacy Keywords
computer-reconstructed radiograph, CRR, plain, radiographs, acetabular, fractures, computed tomography, pushbroom, scanner, ajo, american journal of orthopedics
Legacy Keywords
computer-reconstructed radiograph, CRR, plain, radiographs, acetabular, fractures, computed tomography, pushbroom, scanner, ajo, american journal of orthopedics
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Intraoperative Use of 3-D Fluoroscopy in the Treatment of Developmental Dislocation of the Hip in an Infant

Article Type
Changed
Display Headline
Intraoperative Use of 3-D Fluoroscopy in the Treatment of Developmental Dislocation of the Hip in an Infant

Article PDF
Author and Disclosure Information

Andrew B. Wolff, MD, Matthew E. Oetgen, MD, and Peter A. DeLuca, MD

Dr. Wolff is Resident, and Dr. Oetgen is Resident, Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Connecticut.

Dr. DeLuca is Orthopaedic Surgeon, Connecticut Orthopaedic Specialists, New Haven, Connecticut.

Issue
The American Journal of Orthopedics - 37(9)
Publications
Topics
Page Number
E159-E162
Legacy Keywords
3-d fluoroscopy, developmental dislocation, hip, infant, computed tomography, ct, magnetic resonance imaging, mri, spica cast, pediatrics, ajo, american journal of orthopedics
Sections
Author and Disclosure Information

Andrew B. Wolff, MD, Matthew E. Oetgen, MD, and Peter A. DeLuca, MD

Dr. Wolff is Resident, and Dr. Oetgen is Resident, Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Connecticut.

Dr. DeLuca is Orthopaedic Surgeon, Connecticut Orthopaedic Specialists, New Haven, Connecticut.

Author and Disclosure Information

Andrew B. Wolff, MD, Matthew E. Oetgen, MD, and Peter A. DeLuca, MD

Dr. Wolff is Resident, and Dr. Oetgen is Resident, Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Connecticut.

Dr. DeLuca is Orthopaedic Surgeon, Connecticut Orthopaedic Specialists, New Haven, Connecticut.

Article PDF
Article PDF

Issue
The American Journal of Orthopedics - 37(9)
Issue
The American Journal of Orthopedics - 37(9)
Page Number
E159-E162
Page Number
E159-E162
Publications
Publications
Topics
Article Type
Display Headline
Intraoperative Use of 3-D Fluoroscopy in the Treatment of Developmental Dislocation of the Hip in an Infant
Display Headline
Intraoperative Use of 3-D Fluoroscopy in the Treatment of Developmental Dislocation of the Hip in an Infant
Legacy Keywords
3-d fluoroscopy, developmental dislocation, hip, infant, computed tomography, ct, magnetic resonance imaging, mri, spica cast, pediatrics, ajo, american journal of orthopedics
Legacy Keywords
3-d fluoroscopy, developmental dislocation, hip, infant, computed tomography, ct, magnetic resonance imaging, mri, spica cast, pediatrics, ajo, american journal of orthopedics
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Developmental Dysplasia of the Hip in Infants With Congenital Muscular Torticollis

Article Type
Changed
Display Headline
Developmental Dysplasia of the Hip in Infants With Congenital Muscular Torticollis

Article PDF
Author and Disclosure Information

Keith P. Minihane, MD, John J. Grayhack, MD, Todd D. Simmons, MD, Roopa Seshadri, PhD, Robert W. Wysocki, MD, and John F. Sarwark, MD

Dr. Minihane is Senior Resident, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois.

Dr. Grayhack is Associate Professor, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, and Pediatric Orthopaedic Surgeon, Children's Memorial Hospital, Chicago, Illinois.

Dr. Simmons is Clinical Assistant Professor, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, and Pediatric Orthopaedic Surgeon, Children's Memorial Hospital, Chicago, Illinois.

Dr. Seshadri is Assistant Professor and Statistician, Department of Pediatrics and Preventive Medicine, Northwestern University, Chicago, Illinois.

Dr. Wysocki is Resident, Department of Orthopaedic Surgery, Rush University, Chicago, Illinois.

Dr. Sarwark is Professor, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, and Head, Division of Pediatric Orthopaedic Surgery, Children's Memorial Hospital, Chicago, Illinois.

Issue
The American Journal of Orthopedics - 37(9)
Publications
Topics
Page Number
E155-E158
Legacy Keywords
developmental dysplasia, hip, infants, congenital muscular torticollis, imaging, pediatrics, ajo, american journal of orthopedics
Sections
Author and Disclosure Information

Keith P. Minihane, MD, John J. Grayhack, MD, Todd D. Simmons, MD, Roopa Seshadri, PhD, Robert W. Wysocki, MD, and John F. Sarwark, MD

Dr. Minihane is Senior Resident, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois.

Dr. Grayhack is Associate Professor, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, and Pediatric Orthopaedic Surgeon, Children's Memorial Hospital, Chicago, Illinois.

Dr. Simmons is Clinical Assistant Professor, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, and Pediatric Orthopaedic Surgeon, Children's Memorial Hospital, Chicago, Illinois.

Dr. Seshadri is Assistant Professor and Statistician, Department of Pediatrics and Preventive Medicine, Northwestern University, Chicago, Illinois.

Dr. Wysocki is Resident, Department of Orthopaedic Surgery, Rush University, Chicago, Illinois.

Dr. Sarwark is Professor, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, and Head, Division of Pediatric Orthopaedic Surgery, Children's Memorial Hospital, Chicago, Illinois.

Author and Disclosure Information

Keith P. Minihane, MD, John J. Grayhack, MD, Todd D. Simmons, MD, Roopa Seshadri, PhD, Robert W. Wysocki, MD, and John F. Sarwark, MD

Dr. Minihane is Senior Resident, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois.

Dr. Grayhack is Associate Professor, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, and Pediatric Orthopaedic Surgeon, Children's Memorial Hospital, Chicago, Illinois.

Dr. Simmons is Clinical Assistant Professor, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, and Pediatric Orthopaedic Surgeon, Children's Memorial Hospital, Chicago, Illinois.

Dr. Seshadri is Assistant Professor and Statistician, Department of Pediatrics and Preventive Medicine, Northwestern University, Chicago, Illinois.

Dr. Wysocki is Resident, Department of Orthopaedic Surgery, Rush University, Chicago, Illinois.

Dr. Sarwark is Professor, Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, and Head, Division of Pediatric Orthopaedic Surgery, Children's Memorial Hospital, Chicago, Illinois.

Article PDF
Article PDF

Issue
The American Journal of Orthopedics - 37(9)
Issue
The American Journal of Orthopedics - 37(9)
Page Number
E155-E158
Page Number
E155-E158
Publications
Publications
Topics
Article Type
Display Headline
Developmental Dysplasia of the Hip in Infants With Congenital Muscular Torticollis
Display Headline
Developmental Dysplasia of the Hip in Infants With Congenital Muscular Torticollis
Legacy Keywords
developmental dysplasia, hip, infants, congenital muscular torticollis, imaging, pediatrics, ajo, american journal of orthopedics
Legacy Keywords
developmental dysplasia, hip, infants, congenital muscular torticollis, imaging, pediatrics, ajo, american journal of orthopedics
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Imaging in Development Dysplasia of the Hip: When Less is More

Article Type
Changed
Display Headline
Imaging in Development Dysplasia of the Hip: When Less is More

Article PDF
Author and Disclosure Information

Steve L. Buckley, MD

Dr. Buckley is Director of Pediatric Orthopaedics, The Orthopaedic Center, Huntsville, Alabama.

Issue
The American Journal of Orthopedics - 37(9)
Publications
Topics
Page Number
E149
Legacy Keywords
imaging, development dysplasia, hip, congenital muscular torticollis, computed tomography, pediatrics, 3-D fluoroscopy, ajo, american journal of orthopedics
Sections
Author and Disclosure Information

Steve L. Buckley, MD

Dr. Buckley is Director of Pediatric Orthopaedics, The Orthopaedic Center, Huntsville, Alabama.

Author and Disclosure Information

Steve L. Buckley, MD

Dr. Buckley is Director of Pediatric Orthopaedics, The Orthopaedic Center, Huntsville, Alabama.

Article PDF
Article PDF

Issue
The American Journal of Orthopedics - 37(9)
Issue
The American Journal of Orthopedics - 37(9)
Page Number
E149
Page Number
E149
Publications
Publications
Topics
Article Type
Display Headline
Imaging in Development Dysplasia of the Hip: When Less is More
Display Headline
Imaging in Development Dysplasia of the Hip: When Less is More
Legacy Keywords
imaging, development dysplasia, hip, congenital muscular torticollis, computed tomography, pediatrics, 3-D fluoroscopy, ajo, american journal of orthopedics
Legacy Keywords
imaging, development dysplasia, hip, congenital muscular torticollis, computed tomography, pediatrics, 3-D fluoroscopy, ajo, american journal of orthopedics
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

A 44-year-old man with hemoptysis: A review of pertinent imaging studies and radiographic interventions

Article Type
Changed
Display Headline
A 44-year-old man with hemoptysis: A review of pertinent imaging studies and radiographic interventions

A 44-year-old man comes to the emergency room because of light-headedness and fatigue. He says he has had several similar but milder episodes in the last several months. He also mentions that he thinks he has been coughing up blood. He says he has no major medical or surgical problems of which he is aware, but he appears confused and unable to give an accurate history. No family members can be contacted for further history at the moment.

Physical examination reveals nothing remarkable, but the patient does cough up some blood during the examination. His hemoglobin level is 6.0 g/dL (reference range 13.5–17.5).

What imaging tests would be helpful in this patient’s evaluation?

HEMOPTYSIS HAS MANY CAUSES

Hemoptysis is defined as the expectoration of blood originating from the tracheobronchial tree or the pulmonary parenchyma.

Most cases of hemoptysis are benign and self-limited; life-threatening hemoptysis is rare.1–3 However, hemoptysis can be a sign of serious tracheopulmonary disease.

The bleeding can be from the large (Table 1) or the small (Table 2) pulmonary vessels. Bleeding from the small vessels is known as diffuse alveolar hemorrhage, and it characteristically presents as alveolar infiltrates on chest radiography. In these cases, further imaging studies provide little benefit.4 This paper will focus on the imaging of and radiographic interventions for large-vessel bleeding.

The causes of hemoptysis are numerous; common causes of bleeding from the large vessels nowadays include bronchiectasis, fungal infections, tuberculosis, and cancer.1,5,6 Still, no cause is identified in 15% to 30% of all cases,1,2,5 even after extensive evaluation.

Definition of ‘massive’ hemoptysis can vary

Various definitions of the severity of hemoptysis have been proposed. The threshold of “massive” hemoptysis has been defined as as low as 100 mL/24 hours and as high as 1 L/24 hours; the most common definition is 300 mL, or about 1 cup.2,3,5–10

However, the patient’s cardiorespiratory status must also be considered.5,6,9 If the patient cannot maintain his or her airway, a small amount of bleeding could be life-threatening and should be considered significant or massive. Thus, we define massive hemoptysis as more than 300 mL of blood within 24 hours or any amount of blood with concurrent cardiorespiratory compromise.

It is important to recognize massive hemoptysis quickly, because without urgent treatment, up to 80% of patients may die.5,6,11 This can sometimes pose a challenge, as the history may not always be helpful and the patient’s perception of massive hemoptysis may differ from the clinically accepted definition. For example, in a patient without respiratory compromise, we would not consider bloodtinged sputum or small amounts of blood that add up to 1 to 2 teaspoons (5–10 mL) to be massive, although the patient might. On the other hand, hemoptysis with cardiorespiratory compromise must be considered significant (and very possibly massive) until proven otherwise, even if the amount of blood is small.

Massive hemoptysis is usually the result of erosion of systemic (rather than pulmonary) arteries by bronchial neoplasm, active tuberculosis, or aspergilloma.6,9,12,13 Arteriovenous malformations and pulmonary artery aneurysms are much less common causes.5,11,13

IMAGING AND DIAGNOSTIC OPTIONS

Figure 1.
Most cases of hemoptysis have an identifiable source and cause of the bleeding at the time of initial diagnosis.14 Currently, there is no consensus on what is the best workup for hemoptysis. Still, a complete evaluation includes patient history, physical examination, bronchoscopy, laboratory tests, and imaging studies (Figure 1). Imaging studies that can be helpful include chest radiography, conventional computed tomography (CT), multi-detector CT angiography, and conventional angiography.

Chest radiography

Figure 2. Chest radiograph in a 52-year-old man with cough and hemoptysis. The ill-defined mass in the right lower lobe was found to be squamous cell carcinoma.
Chest radiography is an excellent initial imaging test for evaluating hemoptysis. It is quick and inexpensive and can provide insight into acute chest problems. As mentioned above, in cases of alveolar hemorrhage, radiography typically reveals alveolar infiltrates.4 In cases of hemoptysis due to large-vessel bleeding, radiography can reveal a variety of pertinent findings, such as a mass, pneumonia, chronic lung disease, atelectasis, or a cavitary lesion (FIGURE 2). Even if the findings are nonspecific (such as in pneumonia), radiography can narrow the location of the problem to a single lobe or at least to a single lung, and this information can guide further evaluation by bronchoscopy.4,9

In as many as 40% of cases of hemoptysis, however, the findings on chest radiography are normal or do not reveal the source of the bleeding.15,16 Approximately 5% to 6% of patients with hemoptysis and normal results on radiography are eventually found to have lung cancer.14 Thus, while a localizing finding on radiography is helpful, a normal or nonlocalizing finding warrants further evaluation by other means, including conventional CT, multidetector CT angiography, or bronchoscopy.

 

 

Computed tomography

Figure 3. A computed tomographic scan shows cystic dilatation of the bronchi bilaterally, consistent with cystic bronchiectasis.
Both conventional CT and multidetector CT angiography are quick and noninvasive ways to locate the site of bleeding, determine the cause of bleeding (Figure 3, Figure 4), and create a map to guide further therapy.5,6,11,13

Figure 4. A computed tomographic scan in a 44-year-old man with hemoptysis. The solid mass on the left is a mycetoma within a thin-walled cavity in the left upper lobe.

CT is superior to fiberoptic bronchoscopy in finding a cause of hemoptysis, its main advantage being its ability to show distal airways beyond the reach of the bronchoscope, and the lung parenchyma surrounding these distal airways.5,15,16 In locating the site of bleeding, CT performs about as well as fiberoptic bronchoscopy.5

However, while CT imaging is extremely useful in evaluating bleeding from larger vessels, it adds little information beyond that obtained by chest radiography in cases of diffuse alveolar hemorrhage.4

Multidetector CT angiography is the optimal CT study for evaluating hemoptysis. In addition to showing the lung parenchyma and airways, it allows one to evaluate the integrity of pulmonary, bronchial, and nonbronchial systemic arteries within the chest. It is at least as good as (and, with multiplanar reformatted images, possibly even better than) conventional angiography in evaluating bronchial and nonbronchial systemic arteries. Multidetector CT angiography is recommended before bronchial artery embolization to help one plan the procedure and shorten the procedure time, if the patient is stable enough that this imaging study can be done first.6,12,13

The iodinated contrast material used in CT angiography can cause contrast nephropathy in patients with renal failure. At Cleveland Clinic, we avoid using contrast if the patient’s serum creatinine level is 2.0 mg/dL or greater or if it is rapidly rising, even if it is in the normal range or only slightly elevated; a rapid rise would indicate acute renal failure (eg, in glomerulonephritis). In these cases, we recommend CT without contrast.

CT of the chest has revealed malignancies in cases of hemoptysis in which radiography and bronchoscopy did not.15,17 Although CT is more than 90% sensitive in detecting endobronchial lesions, it has limitations: a blood clot within the bronchus can look like a tumor, and acute bleeding can obscure an endobronchial lesion.5 Thus, bronchoscopy remains an important, complementary diagnostic tool in the evaluation of acute hemoptysis.

Bronchoscopy

Bronchoscopy is overall much less sensitive than CT in detecting the cause of the bleeding,15,16,18 but, if performed early it as useful as CT in finding the site of bleeding,5,9 information that can be helpful in planning further therapy.19 It may be more useful than CT in evaluating endobronchial lesions during acute hemoptysis, as active bleeding can obscure an endobronchial lesion on CT.5 However, the distal airways are often filled with blood, making them difficult to evaluate via bronchoscopy.

In approximately 10% of cases of massive hemoptysis, rigid bronchoscopy is preferred over fiberoptic bronchoscopy, and it is often used in a perioperative setting. However, its use is not usually possible in unstable patients receiving intensive care. Instead, flexible fiberoptic bronchoscopy can be used in patients whose condition is too unstable to allow them to leave the intensive care unit to undergo CT. Flexible fiberoptic bronchoscopy does not require an operating room or anesthesia,19 and can be done in the intensive care unit itself.

Not only can bronchoscopy accurately locate the site of bleeding, it can also aid in controlling the airway in patients with catastrophic hemorrhage and temporarily control bleeding through Fogarty balloon tamponade, direct application of a mixture of epinephrine and cold saline, or topical hemostatic tamponade therapy with a solution of thrombin or fibrinogen and thrombin.2,3,19 It also provides complementary information about endobronchial lesions and is valuable in providing samples for tissue diagnosis and microbial cultures.

Diagnostic angiography has limitations

Although it is possible to bypass radiography, CT, and bronchoscopy in a case of massive hemoptysis and to rush the patient to the angiography suite for combined diagnostic angiography and therapeutic bronchial artery embolization, this approach has limitations. Diagnostic angiography does not identify the source of bleeding as well as CT does.6 It is important to locate the bleeding site first via CT, multidetector CT angiography, or bronchoscopy. Diagnostic angiography can be time-consuming. The procedure time can be significantly shorter if CT, bronchoscopy, or both are done first to ascertain the site of bleeding before bronchial artery embolization.1,6 Another reason that performing CT first is important is that it can rule out situations in which surgery would be preferred over bronchial artery embolization.6

In more than 90% of cases of hemoptysis requiring embolization or surgery, the bleeding is from the bronchial arteries.5,6,9,11–13 However, bronchoscopy before bronchial artery embolization is unnecessary in patients with hemoptysis of known cause if the site of bleeding can be determined from radiography or CT and if no bronchoscopic airway management is needed.18

 

 

BRONCHIAL ARTERY EMBOLIZATION: AN ALTERNATIVE TO SURGERY

After a cause of the hemoptysis has been established by radiography, CT, or bronchoscopy, bronchial artery embolization is an effective first-line therapy to control massive, life-threatening bleeding.6 It is an alternative in patients who cannot undergo surgery because of bilateral or extensive disease that renders them unable to tolerate life after a lobectomy.6,12,18

Indications for bronchial artery embolization include failure of conservative management, massive hemoptysis, recurrent hemoptysis, and poor surgical risk. It is also done to control bleeding temporarily before surgery.1

Another indication for this therapy is peripheral pulmonary artery pseudoaneurysm, which is found in up to 11% of patients undergoing bronchial angiography for hemoptysis. These patients typically present with recurrent hemoptysis (sometimes massive) and occasionally with both hemoptysis and clubbing. Most of these patients have either chronic active pulmonary tuberculosis or a mycetoma complicating sarcoidosis or tuberculosis. Occlusion of the pulmonary artery pseudoaneurysm may require embolization of bronchial arteries, nonbronchial systemic arteries, or pulmonary artery branches.20

Surgery, however, is still the definitive treatment of choice for thoracic vascular injury, bronchial adenoma, aspergilloma resistant to other therapies, and hydatid cyst.6 A cardiothoracic surgeon should be consulted in these cases.

Outcomes of embolization

Images courtesy of Abraham Levitin, MD.
Figure 5. A pathologic bronchial artery to a mediastinal tumor before (left) and after (right) embolization with polyvinyl alcohol particles.
Aside from the cases in which surgery is indicated, bronchial artery embolization (Figure 5) is a very successful minimally invasive therapy that controls bleeding immediately in 66% to 90% of patients.1,7,21 It is the preferred emergency treatment for massive hemoptysis, as the death rate is 7.1% to 18.2%, which, though high, is considerably less than the 40% seen in emergency surgery for massive hemoptysis.6

If a patient with massive hemoptysis undergoes successful bronchial artery embolization but the bleeding recurs 1 to 6 months later, the cause is likely an undetected nonbronchial systemic arterial supply and incomplete embolization.1,22 Late rebleeding (6–12 months after the procedure) occurs in 20% to 40% of patients and is likely to be from disease progression.1,7

Common complications of bronchial artery embolization are transient chest pain and dysphagia. Very rare complications include subintimal dissection and spinal cord ischemia due to inadvertent occlusion of the spinal arteries.6 Another complication in patients with renal failure is contrast nephropathy, the risk of which must be weighed against the possible consequences—including death—of not performing bronchial artery embolization in a patient who cannot undergo surgery.

CASE REVISITED: CLINICAL COURSE

In the patient described at the beginning of this article, a chest radiograph obtained in the emergency room showed an area of nonspecific consolidation in the left upper lung. Conventional chest CT was then ordered (Figure 4), and it revealed a cavitary lesion in the left upper lobe, consistent with aspergilloma. Bronchoscopy was then performed, and it too indicated that the bleeding was coming from the left upper lobe. Samples obtained during the procedure were sent to the laboratory for bacterial and fungal cultures.

In the meantime, family members were contacted, and they revealed that the patient had a history of sarcoidosis.

The patient went on to develop massive hemoptysis. Although the treatment of choice for mycetoma is primary resection, our patient’s respiratory status was poor as a result of extensive pulmonary sarcoidosis, and he was not considered a candidate for emergency surgery at that time. He was rushed to the angiography suite and successfully underwent emergency bronchial artery embolization.

References
  1. Andersen PE. Imaging and interventional radiological treatment of hemoptysis. Acta Radiologica 2006; 47:780792.
  2. Corder R. Hemoptysis. Emerg Med Clin North Am 2003; 21:421435.
  3. Valipour A, Kreuzer A, Koller H, Koessler W, Burghuber OC. Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis. Chest 2005; 127:21132118.
  4. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med 2004; 25:583592.
  5. Khalil A, Soussan M, Mangiapan G, Fartoukh M, Parrot A, Carette MF. Utility of high-resolution chest CT scan in the emergency management of haemoptysis in the intensive care unit: severity, localization and aetiology. Br J Radiol 2007; 80:2125.
  6. Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics 2002; 22:13951409.
  7. Johnson JL. Manifestations of hemoptysis. How to manage minor, moderate, and massive bleeding. Postgrad Med 2002; 112 4:101113.
  8. Bidwell JL, Pachner RW. Hemoptysis: diagnosis and management. Am Fam Phys 2005; 72:12531260.
  9. Bruzzi JF, Remy-Jardin M, Delhaye D, Teisseire A, Khalil C, Remy J. Multi-detector row CT of hemoptysis. Radiographics 2006; 26:322.
  10. Ozgul MA, Turna A, Yildiz P, Ertan E, Kahraman S, Yilmaz V. Risk factors and recurrence patterns in 203 patients with hemoptysis. Tuberk Toraks 2006; 54:243248.
  11. Khalil A, Fartoukh M, Tassart M, Parrot A, Marsault C, Carette MF. Role of MDCT in identification of the bleeding site and the vessels causing hemoptysis. AJR Am J Roentgenol 2007; 188:W117W125.
  12. Remy-Jardin M, Bouaziz N, Dumont P, Brillet PY, Bruzzi J, Remy J. Bronchial and nonbronchial systemic arteries at multi-detector row CT angiography: comparison with conventional angiography. Radiology 2004; 233:741749.
  13. Yoon YC, Lee KS, Jeong YJ, Shin SW, Chung MJ, Kwon OJ. Hemoptysis: bronchial and nonbronchial systemic arteries at 16-detector row CT. Radiology 2005; 234:292298.
  14. Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest 2001; 120:15921594.
  15. Naidich DP, Funt S, Ettenger NA, Arranda C. Hemoptysis: CT-bronchoscopic correlations in 58 cases. Radiology 1990; 177:357362.
  16. McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 1994; 105:11551162.
  17. Revel MP, Fournier LS, Hennebicque AS, et al. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol 2002; 179:12171224.
  18. Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol 2001; 177:861867.
  19. Raoof S, Mehrishi S, Prakash UB. Role of bronchoscopy in modern medical intensive care unit. Clin Chest Med 2001; 22:241261.
  20. Sbano H, Mitchell AW, Ind PW, Jackson JE. Peripheral pulmonary artery pseudoaneurysms and massive hemoptysis. AJR Am J Roentgenol 2005; 184:12531259.
  21. Swanson KL, Johnson CM, Prakash UB, McKusick MA, Andrews JC, Stanson AW. Bronchial artery embolization: experience with 54 patients. Chest 2002; 121:789795.
  22. Yoon W, Kim YH, Kim JK, Kim YC, Park JG, Kang HK. Massive hemoptysis: prediction of nonbronchial systemic arterial supply with chest CT. Radiology 2003; 227:232238.
Article PDF
Author and Disclosure Information

Arlene Sirajuddin, MD
Section of Thoracic Imaging, Imaging Institute, Cleveland Clinic

Tan-Lucien H. Mohammed, MD
Section of Thoracic Imaging, Imaging Institute, Cleveland Clinic

Address: Tan-Lucien H. Mohammed, MD, Section of Thoracic Imaging, Division of Radiology, Hb6, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 75(8)
Publications
Topics
Page Number
601-607
Sections
Author and Disclosure Information

Arlene Sirajuddin, MD
Section of Thoracic Imaging, Imaging Institute, Cleveland Clinic

Tan-Lucien H. Mohammed, MD
Section of Thoracic Imaging, Imaging Institute, Cleveland Clinic

Address: Tan-Lucien H. Mohammed, MD, Section of Thoracic Imaging, Division of Radiology, Hb6, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Arlene Sirajuddin, MD
Section of Thoracic Imaging, Imaging Institute, Cleveland Clinic

Tan-Lucien H. Mohammed, MD
Section of Thoracic Imaging, Imaging Institute, Cleveland Clinic

Address: Tan-Lucien H. Mohammed, MD, Section of Thoracic Imaging, Division of Radiology, Hb6, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF

A 44-year-old man comes to the emergency room because of light-headedness and fatigue. He says he has had several similar but milder episodes in the last several months. He also mentions that he thinks he has been coughing up blood. He says he has no major medical or surgical problems of which he is aware, but he appears confused and unable to give an accurate history. No family members can be contacted for further history at the moment.

Physical examination reveals nothing remarkable, but the patient does cough up some blood during the examination. His hemoglobin level is 6.0 g/dL (reference range 13.5–17.5).

What imaging tests would be helpful in this patient’s evaluation?

HEMOPTYSIS HAS MANY CAUSES

Hemoptysis is defined as the expectoration of blood originating from the tracheobronchial tree or the pulmonary parenchyma.

Most cases of hemoptysis are benign and self-limited; life-threatening hemoptysis is rare.1–3 However, hemoptysis can be a sign of serious tracheopulmonary disease.

The bleeding can be from the large (Table 1) or the small (Table 2) pulmonary vessels. Bleeding from the small vessels is known as diffuse alveolar hemorrhage, and it characteristically presents as alveolar infiltrates on chest radiography. In these cases, further imaging studies provide little benefit.4 This paper will focus on the imaging of and radiographic interventions for large-vessel bleeding.

The causes of hemoptysis are numerous; common causes of bleeding from the large vessels nowadays include bronchiectasis, fungal infections, tuberculosis, and cancer.1,5,6 Still, no cause is identified in 15% to 30% of all cases,1,2,5 even after extensive evaluation.

Definition of ‘massive’ hemoptysis can vary

Various definitions of the severity of hemoptysis have been proposed. The threshold of “massive” hemoptysis has been defined as as low as 100 mL/24 hours and as high as 1 L/24 hours; the most common definition is 300 mL, or about 1 cup.2,3,5–10

However, the patient’s cardiorespiratory status must also be considered.5,6,9 If the patient cannot maintain his or her airway, a small amount of bleeding could be life-threatening and should be considered significant or massive. Thus, we define massive hemoptysis as more than 300 mL of blood within 24 hours or any amount of blood with concurrent cardiorespiratory compromise.

It is important to recognize massive hemoptysis quickly, because without urgent treatment, up to 80% of patients may die.5,6,11 This can sometimes pose a challenge, as the history may not always be helpful and the patient’s perception of massive hemoptysis may differ from the clinically accepted definition. For example, in a patient without respiratory compromise, we would not consider bloodtinged sputum or small amounts of blood that add up to 1 to 2 teaspoons (5–10 mL) to be massive, although the patient might. On the other hand, hemoptysis with cardiorespiratory compromise must be considered significant (and very possibly massive) until proven otherwise, even if the amount of blood is small.

Massive hemoptysis is usually the result of erosion of systemic (rather than pulmonary) arteries by bronchial neoplasm, active tuberculosis, or aspergilloma.6,9,12,13 Arteriovenous malformations and pulmonary artery aneurysms are much less common causes.5,11,13

IMAGING AND DIAGNOSTIC OPTIONS

Figure 1.
Most cases of hemoptysis have an identifiable source and cause of the bleeding at the time of initial diagnosis.14 Currently, there is no consensus on what is the best workup for hemoptysis. Still, a complete evaluation includes patient history, physical examination, bronchoscopy, laboratory tests, and imaging studies (Figure 1). Imaging studies that can be helpful include chest radiography, conventional computed tomography (CT), multi-detector CT angiography, and conventional angiography.

Chest radiography

Figure 2. Chest radiograph in a 52-year-old man with cough and hemoptysis. The ill-defined mass in the right lower lobe was found to be squamous cell carcinoma.
Chest radiography is an excellent initial imaging test for evaluating hemoptysis. It is quick and inexpensive and can provide insight into acute chest problems. As mentioned above, in cases of alveolar hemorrhage, radiography typically reveals alveolar infiltrates.4 In cases of hemoptysis due to large-vessel bleeding, radiography can reveal a variety of pertinent findings, such as a mass, pneumonia, chronic lung disease, atelectasis, or a cavitary lesion (FIGURE 2). Even if the findings are nonspecific (such as in pneumonia), radiography can narrow the location of the problem to a single lobe or at least to a single lung, and this information can guide further evaluation by bronchoscopy.4,9

In as many as 40% of cases of hemoptysis, however, the findings on chest radiography are normal or do not reveal the source of the bleeding.15,16 Approximately 5% to 6% of patients with hemoptysis and normal results on radiography are eventually found to have lung cancer.14 Thus, while a localizing finding on radiography is helpful, a normal or nonlocalizing finding warrants further evaluation by other means, including conventional CT, multidetector CT angiography, or bronchoscopy.

 

 

Computed tomography

Figure 3. A computed tomographic scan shows cystic dilatation of the bronchi bilaterally, consistent with cystic bronchiectasis.
Both conventional CT and multidetector CT angiography are quick and noninvasive ways to locate the site of bleeding, determine the cause of bleeding (Figure 3, Figure 4), and create a map to guide further therapy.5,6,11,13

Figure 4. A computed tomographic scan in a 44-year-old man with hemoptysis. The solid mass on the left is a mycetoma within a thin-walled cavity in the left upper lobe.

CT is superior to fiberoptic bronchoscopy in finding a cause of hemoptysis, its main advantage being its ability to show distal airways beyond the reach of the bronchoscope, and the lung parenchyma surrounding these distal airways.5,15,16 In locating the site of bleeding, CT performs about as well as fiberoptic bronchoscopy.5

However, while CT imaging is extremely useful in evaluating bleeding from larger vessels, it adds little information beyond that obtained by chest radiography in cases of diffuse alveolar hemorrhage.4

Multidetector CT angiography is the optimal CT study for evaluating hemoptysis. In addition to showing the lung parenchyma and airways, it allows one to evaluate the integrity of pulmonary, bronchial, and nonbronchial systemic arteries within the chest. It is at least as good as (and, with multiplanar reformatted images, possibly even better than) conventional angiography in evaluating bronchial and nonbronchial systemic arteries. Multidetector CT angiography is recommended before bronchial artery embolization to help one plan the procedure and shorten the procedure time, if the patient is stable enough that this imaging study can be done first.6,12,13

The iodinated contrast material used in CT angiography can cause contrast nephropathy in patients with renal failure. At Cleveland Clinic, we avoid using contrast if the patient’s serum creatinine level is 2.0 mg/dL or greater or if it is rapidly rising, even if it is in the normal range or only slightly elevated; a rapid rise would indicate acute renal failure (eg, in glomerulonephritis). In these cases, we recommend CT without contrast.

CT of the chest has revealed malignancies in cases of hemoptysis in which radiography and bronchoscopy did not.15,17 Although CT is more than 90% sensitive in detecting endobronchial lesions, it has limitations: a blood clot within the bronchus can look like a tumor, and acute bleeding can obscure an endobronchial lesion.5 Thus, bronchoscopy remains an important, complementary diagnostic tool in the evaluation of acute hemoptysis.

Bronchoscopy

Bronchoscopy is overall much less sensitive than CT in detecting the cause of the bleeding,15,16,18 but, if performed early it as useful as CT in finding the site of bleeding,5,9 information that can be helpful in planning further therapy.19 It may be more useful than CT in evaluating endobronchial lesions during acute hemoptysis, as active bleeding can obscure an endobronchial lesion on CT.5 However, the distal airways are often filled with blood, making them difficult to evaluate via bronchoscopy.

In approximately 10% of cases of massive hemoptysis, rigid bronchoscopy is preferred over fiberoptic bronchoscopy, and it is often used in a perioperative setting. However, its use is not usually possible in unstable patients receiving intensive care. Instead, flexible fiberoptic bronchoscopy can be used in patients whose condition is too unstable to allow them to leave the intensive care unit to undergo CT. Flexible fiberoptic bronchoscopy does not require an operating room or anesthesia,19 and can be done in the intensive care unit itself.

Not only can bronchoscopy accurately locate the site of bleeding, it can also aid in controlling the airway in patients with catastrophic hemorrhage and temporarily control bleeding through Fogarty balloon tamponade, direct application of a mixture of epinephrine and cold saline, or topical hemostatic tamponade therapy with a solution of thrombin or fibrinogen and thrombin.2,3,19 It also provides complementary information about endobronchial lesions and is valuable in providing samples for tissue diagnosis and microbial cultures.

Diagnostic angiography has limitations

Although it is possible to bypass radiography, CT, and bronchoscopy in a case of massive hemoptysis and to rush the patient to the angiography suite for combined diagnostic angiography and therapeutic bronchial artery embolization, this approach has limitations. Diagnostic angiography does not identify the source of bleeding as well as CT does.6 It is important to locate the bleeding site first via CT, multidetector CT angiography, or bronchoscopy. Diagnostic angiography can be time-consuming. The procedure time can be significantly shorter if CT, bronchoscopy, or both are done first to ascertain the site of bleeding before bronchial artery embolization.1,6 Another reason that performing CT first is important is that it can rule out situations in which surgery would be preferred over bronchial artery embolization.6

In more than 90% of cases of hemoptysis requiring embolization or surgery, the bleeding is from the bronchial arteries.5,6,9,11–13 However, bronchoscopy before bronchial artery embolization is unnecessary in patients with hemoptysis of known cause if the site of bleeding can be determined from radiography or CT and if no bronchoscopic airway management is needed.18

 

 

BRONCHIAL ARTERY EMBOLIZATION: AN ALTERNATIVE TO SURGERY

After a cause of the hemoptysis has been established by radiography, CT, or bronchoscopy, bronchial artery embolization is an effective first-line therapy to control massive, life-threatening bleeding.6 It is an alternative in patients who cannot undergo surgery because of bilateral or extensive disease that renders them unable to tolerate life after a lobectomy.6,12,18

Indications for bronchial artery embolization include failure of conservative management, massive hemoptysis, recurrent hemoptysis, and poor surgical risk. It is also done to control bleeding temporarily before surgery.1

Another indication for this therapy is peripheral pulmonary artery pseudoaneurysm, which is found in up to 11% of patients undergoing bronchial angiography for hemoptysis. These patients typically present with recurrent hemoptysis (sometimes massive) and occasionally with both hemoptysis and clubbing. Most of these patients have either chronic active pulmonary tuberculosis or a mycetoma complicating sarcoidosis or tuberculosis. Occlusion of the pulmonary artery pseudoaneurysm may require embolization of bronchial arteries, nonbronchial systemic arteries, or pulmonary artery branches.20

Surgery, however, is still the definitive treatment of choice for thoracic vascular injury, bronchial adenoma, aspergilloma resistant to other therapies, and hydatid cyst.6 A cardiothoracic surgeon should be consulted in these cases.

Outcomes of embolization

Images courtesy of Abraham Levitin, MD.
Figure 5. A pathologic bronchial artery to a mediastinal tumor before (left) and after (right) embolization with polyvinyl alcohol particles.
Aside from the cases in which surgery is indicated, bronchial artery embolization (Figure 5) is a very successful minimally invasive therapy that controls bleeding immediately in 66% to 90% of patients.1,7,21 It is the preferred emergency treatment for massive hemoptysis, as the death rate is 7.1% to 18.2%, which, though high, is considerably less than the 40% seen in emergency surgery for massive hemoptysis.6

If a patient with massive hemoptysis undergoes successful bronchial artery embolization but the bleeding recurs 1 to 6 months later, the cause is likely an undetected nonbronchial systemic arterial supply and incomplete embolization.1,22 Late rebleeding (6–12 months after the procedure) occurs in 20% to 40% of patients and is likely to be from disease progression.1,7

Common complications of bronchial artery embolization are transient chest pain and dysphagia. Very rare complications include subintimal dissection and spinal cord ischemia due to inadvertent occlusion of the spinal arteries.6 Another complication in patients with renal failure is contrast nephropathy, the risk of which must be weighed against the possible consequences—including death—of not performing bronchial artery embolization in a patient who cannot undergo surgery.

CASE REVISITED: CLINICAL COURSE

In the patient described at the beginning of this article, a chest radiograph obtained in the emergency room showed an area of nonspecific consolidation in the left upper lung. Conventional chest CT was then ordered (Figure 4), and it revealed a cavitary lesion in the left upper lobe, consistent with aspergilloma. Bronchoscopy was then performed, and it too indicated that the bleeding was coming from the left upper lobe. Samples obtained during the procedure were sent to the laboratory for bacterial and fungal cultures.

In the meantime, family members were contacted, and they revealed that the patient had a history of sarcoidosis.

The patient went on to develop massive hemoptysis. Although the treatment of choice for mycetoma is primary resection, our patient’s respiratory status was poor as a result of extensive pulmonary sarcoidosis, and he was not considered a candidate for emergency surgery at that time. He was rushed to the angiography suite and successfully underwent emergency bronchial artery embolization.

A 44-year-old man comes to the emergency room because of light-headedness and fatigue. He says he has had several similar but milder episodes in the last several months. He also mentions that he thinks he has been coughing up blood. He says he has no major medical or surgical problems of which he is aware, but he appears confused and unable to give an accurate history. No family members can be contacted for further history at the moment.

Physical examination reveals nothing remarkable, but the patient does cough up some blood during the examination. His hemoglobin level is 6.0 g/dL (reference range 13.5–17.5).

What imaging tests would be helpful in this patient’s evaluation?

HEMOPTYSIS HAS MANY CAUSES

Hemoptysis is defined as the expectoration of blood originating from the tracheobronchial tree or the pulmonary parenchyma.

Most cases of hemoptysis are benign and self-limited; life-threatening hemoptysis is rare.1–3 However, hemoptysis can be a sign of serious tracheopulmonary disease.

The bleeding can be from the large (Table 1) or the small (Table 2) pulmonary vessels. Bleeding from the small vessels is known as diffuse alveolar hemorrhage, and it characteristically presents as alveolar infiltrates on chest radiography. In these cases, further imaging studies provide little benefit.4 This paper will focus on the imaging of and radiographic interventions for large-vessel bleeding.

The causes of hemoptysis are numerous; common causes of bleeding from the large vessels nowadays include bronchiectasis, fungal infections, tuberculosis, and cancer.1,5,6 Still, no cause is identified in 15% to 30% of all cases,1,2,5 even after extensive evaluation.

Definition of ‘massive’ hemoptysis can vary

Various definitions of the severity of hemoptysis have been proposed. The threshold of “massive” hemoptysis has been defined as as low as 100 mL/24 hours and as high as 1 L/24 hours; the most common definition is 300 mL, or about 1 cup.2,3,5–10

However, the patient’s cardiorespiratory status must also be considered.5,6,9 If the patient cannot maintain his or her airway, a small amount of bleeding could be life-threatening and should be considered significant or massive. Thus, we define massive hemoptysis as more than 300 mL of blood within 24 hours or any amount of blood with concurrent cardiorespiratory compromise.

It is important to recognize massive hemoptysis quickly, because without urgent treatment, up to 80% of patients may die.5,6,11 This can sometimes pose a challenge, as the history may not always be helpful and the patient’s perception of massive hemoptysis may differ from the clinically accepted definition. For example, in a patient without respiratory compromise, we would not consider bloodtinged sputum or small amounts of blood that add up to 1 to 2 teaspoons (5–10 mL) to be massive, although the patient might. On the other hand, hemoptysis with cardiorespiratory compromise must be considered significant (and very possibly massive) until proven otherwise, even if the amount of blood is small.

Massive hemoptysis is usually the result of erosion of systemic (rather than pulmonary) arteries by bronchial neoplasm, active tuberculosis, or aspergilloma.6,9,12,13 Arteriovenous malformations and pulmonary artery aneurysms are much less common causes.5,11,13

IMAGING AND DIAGNOSTIC OPTIONS

Figure 1.
Most cases of hemoptysis have an identifiable source and cause of the bleeding at the time of initial diagnosis.14 Currently, there is no consensus on what is the best workup for hemoptysis. Still, a complete evaluation includes patient history, physical examination, bronchoscopy, laboratory tests, and imaging studies (Figure 1). Imaging studies that can be helpful include chest radiography, conventional computed tomography (CT), multi-detector CT angiography, and conventional angiography.

Chest radiography

Figure 2. Chest radiograph in a 52-year-old man with cough and hemoptysis. The ill-defined mass in the right lower lobe was found to be squamous cell carcinoma.
Chest radiography is an excellent initial imaging test for evaluating hemoptysis. It is quick and inexpensive and can provide insight into acute chest problems. As mentioned above, in cases of alveolar hemorrhage, radiography typically reveals alveolar infiltrates.4 In cases of hemoptysis due to large-vessel bleeding, radiography can reveal a variety of pertinent findings, such as a mass, pneumonia, chronic lung disease, atelectasis, or a cavitary lesion (FIGURE 2). Even if the findings are nonspecific (such as in pneumonia), radiography can narrow the location of the problem to a single lobe or at least to a single lung, and this information can guide further evaluation by bronchoscopy.4,9

In as many as 40% of cases of hemoptysis, however, the findings on chest radiography are normal or do not reveal the source of the bleeding.15,16 Approximately 5% to 6% of patients with hemoptysis and normal results on radiography are eventually found to have lung cancer.14 Thus, while a localizing finding on radiography is helpful, a normal or nonlocalizing finding warrants further evaluation by other means, including conventional CT, multidetector CT angiography, or bronchoscopy.

 

 

Computed tomography

Figure 3. A computed tomographic scan shows cystic dilatation of the bronchi bilaterally, consistent with cystic bronchiectasis.
Both conventional CT and multidetector CT angiography are quick and noninvasive ways to locate the site of bleeding, determine the cause of bleeding (Figure 3, Figure 4), and create a map to guide further therapy.5,6,11,13

Figure 4. A computed tomographic scan in a 44-year-old man with hemoptysis. The solid mass on the left is a mycetoma within a thin-walled cavity in the left upper lobe.

CT is superior to fiberoptic bronchoscopy in finding a cause of hemoptysis, its main advantage being its ability to show distal airways beyond the reach of the bronchoscope, and the lung parenchyma surrounding these distal airways.5,15,16 In locating the site of bleeding, CT performs about as well as fiberoptic bronchoscopy.5

However, while CT imaging is extremely useful in evaluating bleeding from larger vessels, it adds little information beyond that obtained by chest radiography in cases of diffuse alveolar hemorrhage.4

Multidetector CT angiography is the optimal CT study for evaluating hemoptysis. In addition to showing the lung parenchyma and airways, it allows one to evaluate the integrity of pulmonary, bronchial, and nonbronchial systemic arteries within the chest. It is at least as good as (and, with multiplanar reformatted images, possibly even better than) conventional angiography in evaluating bronchial and nonbronchial systemic arteries. Multidetector CT angiography is recommended before bronchial artery embolization to help one plan the procedure and shorten the procedure time, if the patient is stable enough that this imaging study can be done first.6,12,13

The iodinated contrast material used in CT angiography can cause contrast nephropathy in patients with renal failure. At Cleveland Clinic, we avoid using contrast if the patient’s serum creatinine level is 2.0 mg/dL or greater or if it is rapidly rising, even if it is in the normal range or only slightly elevated; a rapid rise would indicate acute renal failure (eg, in glomerulonephritis). In these cases, we recommend CT without contrast.

CT of the chest has revealed malignancies in cases of hemoptysis in which radiography and bronchoscopy did not.15,17 Although CT is more than 90% sensitive in detecting endobronchial lesions, it has limitations: a blood clot within the bronchus can look like a tumor, and acute bleeding can obscure an endobronchial lesion.5 Thus, bronchoscopy remains an important, complementary diagnostic tool in the evaluation of acute hemoptysis.

Bronchoscopy

Bronchoscopy is overall much less sensitive than CT in detecting the cause of the bleeding,15,16,18 but, if performed early it as useful as CT in finding the site of bleeding,5,9 information that can be helpful in planning further therapy.19 It may be more useful than CT in evaluating endobronchial lesions during acute hemoptysis, as active bleeding can obscure an endobronchial lesion on CT.5 However, the distal airways are often filled with blood, making them difficult to evaluate via bronchoscopy.

In approximately 10% of cases of massive hemoptysis, rigid bronchoscopy is preferred over fiberoptic bronchoscopy, and it is often used in a perioperative setting. However, its use is not usually possible in unstable patients receiving intensive care. Instead, flexible fiberoptic bronchoscopy can be used in patients whose condition is too unstable to allow them to leave the intensive care unit to undergo CT. Flexible fiberoptic bronchoscopy does not require an operating room or anesthesia,19 and can be done in the intensive care unit itself.

Not only can bronchoscopy accurately locate the site of bleeding, it can also aid in controlling the airway in patients with catastrophic hemorrhage and temporarily control bleeding through Fogarty balloon tamponade, direct application of a mixture of epinephrine and cold saline, or topical hemostatic tamponade therapy with a solution of thrombin or fibrinogen and thrombin.2,3,19 It also provides complementary information about endobronchial lesions and is valuable in providing samples for tissue diagnosis and microbial cultures.

Diagnostic angiography has limitations

Although it is possible to bypass radiography, CT, and bronchoscopy in a case of massive hemoptysis and to rush the patient to the angiography suite for combined diagnostic angiography and therapeutic bronchial artery embolization, this approach has limitations. Diagnostic angiography does not identify the source of bleeding as well as CT does.6 It is important to locate the bleeding site first via CT, multidetector CT angiography, or bronchoscopy. Diagnostic angiography can be time-consuming. The procedure time can be significantly shorter if CT, bronchoscopy, or both are done first to ascertain the site of bleeding before bronchial artery embolization.1,6 Another reason that performing CT first is important is that it can rule out situations in which surgery would be preferred over bronchial artery embolization.6

In more than 90% of cases of hemoptysis requiring embolization or surgery, the bleeding is from the bronchial arteries.5,6,9,11–13 However, bronchoscopy before bronchial artery embolization is unnecessary in patients with hemoptysis of known cause if the site of bleeding can be determined from radiography or CT and if no bronchoscopic airway management is needed.18

 

 

BRONCHIAL ARTERY EMBOLIZATION: AN ALTERNATIVE TO SURGERY

After a cause of the hemoptysis has been established by radiography, CT, or bronchoscopy, bronchial artery embolization is an effective first-line therapy to control massive, life-threatening bleeding.6 It is an alternative in patients who cannot undergo surgery because of bilateral or extensive disease that renders them unable to tolerate life after a lobectomy.6,12,18

Indications for bronchial artery embolization include failure of conservative management, massive hemoptysis, recurrent hemoptysis, and poor surgical risk. It is also done to control bleeding temporarily before surgery.1

Another indication for this therapy is peripheral pulmonary artery pseudoaneurysm, which is found in up to 11% of patients undergoing bronchial angiography for hemoptysis. These patients typically present with recurrent hemoptysis (sometimes massive) and occasionally with both hemoptysis and clubbing. Most of these patients have either chronic active pulmonary tuberculosis or a mycetoma complicating sarcoidosis or tuberculosis. Occlusion of the pulmonary artery pseudoaneurysm may require embolization of bronchial arteries, nonbronchial systemic arteries, or pulmonary artery branches.20

Surgery, however, is still the definitive treatment of choice for thoracic vascular injury, bronchial adenoma, aspergilloma resistant to other therapies, and hydatid cyst.6 A cardiothoracic surgeon should be consulted in these cases.

Outcomes of embolization

Images courtesy of Abraham Levitin, MD.
Figure 5. A pathologic bronchial artery to a mediastinal tumor before (left) and after (right) embolization with polyvinyl alcohol particles.
Aside from the cases in which surgery is indicated, bronchial artery embolization (Figure 5) is a very successful minimally invasive therapy that controls bleeding immediately in 66% to 90% of patients.1,7,21 It is the preferred emergency treatment for massive hemoptysis, as the death rate is 7.1% to 18.2%, which, though high, is considerably less than the 40% seen in emergency surgery for massive hemoptysis.6

If a patient with massive hemoptysis undergoes successful bronchial artery embolization but the bleeding recurs 1 to 6 months later, the cause is likely an undetected nonbronchial systemic arterial supply and incomplete embolization.1,22 Late rebleeding (6–12 months after the procedure) occurs in 20% to 40% of patients and is likely to be from disease progression.1,7

Common complications of bronchial artery embolization are transient chest pain and dysphagia. Very rare complications include subintimal dissection and spinal cord ischemia due to inadvertent occlusion of the spinal arteries.6 Another complication in patients with renal failure is contrast nephropathy, the risk of which must be weighed against the possible consequences—including death—of not performing bronchial artery embolization in a patient who cannot undergo surgery.

CASE REVISITED: CLINICAL COURSE

In the patient described at the beginning of this article, a chest radiograph obtained in the emergency room showed an area of nonspecific consolidation in the left upper lung. Conventional chest CT was then ordered (Figure 4), and it revealed a cavitary lesion in the left upper lobe, consistent with aspergilloma. Bronchoscopy was then performed, and it too indicated that the bleeding was coming from the left upper lobe. Samples obtained during the procedure were sent to the laboratory for bacterial and fungal cultures.

In the meantime, family members were contacted, and they revealed that the patient had a history of sarcoidosis.

The patient went on to develop massive hemoptysis. Although the treatment of choice for mycetoma is primary resection, our patient’s respiratory status was poor as a result of extensive pulmonary sarcoidosis, and he was not considered a candidate for emergency surgery at that time. He was rushed to the angiography suite and successfully underwent emergency bronchial artery embolization.

References
  1. Andersen PE. Imaging and interventional radiological treatment of hemoptysis. Acta Radiologica 2006; 47:780792.
  2. Corder R. Hemoptysis. Emerg Med Clin North Am 2003; 21:421435.
  3. Valipour A, Kreuzer A, Koller H, Koessler W, Burghuber OC. Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis. Chest 2005; 127:21132118.
  4. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med 2004; 25:583592.
  5. Khalil A, Soussan M, Mangiapan G, Fartoukh M, Parrot A, Carette MF. Utility of high-resolution chest CT scan in the emergency management of haemoptysis in the intensive care unit: severity, localization and aetiology. Br J Radiol 2007; 80:2125.
  6. Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics 2002; 22:13951409.
  7. Johnson JL. Manifestations of hemoptysis. How to manage minor, moderate, and massive bleeding. Postgrad Med 2002; 112 4:101113.
  8. Bidwell JL, Pachner RW. Hemoptysis: diagnosis and management. Am Fam Phys 2005; 72:12531260.
  9. Bruzzi JF, Remy-Jardin M, Delhaye D, Teisseire A, Khalil C, Remy J. Multi-detector row CT of hemoptysis. Radiographics 2006; 26:322.
  10. Ozgul MA, Turna A, Yildiz P, Ertan E, Kahraman S, Yilmaz V. Risk factors and recurrence patterns in 203 patients with hemoptysis. Tuberk Toraks 2006; 54:243248.
  11. Khalil A, Fartoukh M, Tassart M, Parrot A, Marsault C, Carette MF. Role of MDCT in identification of the bleeding site and the vessels causing hemoptysis. AJR Am J Roentgenol 2007; 188:W117W125.
  12. Remy-Jardin M, Bouaziz N, Dumont P, Brillet PY, Bruzzi J, Remy J. Bronchial and nonbronchial systemic arteries at multi-detector row CT angiography: comparison with conventional angiography. Radiology 2004; 233:741749.
  13. Yoon YC, Lee KS, Jeong YJ, Shin SW, Chung MJ, Kwon OJ. Hemoptysis: bronchial and nonbronchial systemic arteries at 16-detector row CT. Radiology 2005; 234:292298.
  14. Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest 2001; 120:15921594.
  15. Naidich DP, Funt S, Ettenger NA, Arranda C. Hemoptysis: CT-bronchoscopic correlations in 58 cases. Radiology 1990; 177:357362.
  16. McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 1994; 105:11551162.
  17. Revel MP, Fournier LS, Hennebicque AS, et al. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol 2002; 179:12171224.
  18. Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol 2001; 177:861867.
  19. Raoof S, Mehrishi S, Prakash UB. Role of bronchoscopy in modern medical intensive care unit. Clin Chest Med 2001; 22:241261.
  20. Sbano H, Mitchell AW, Ind PW, Jackson JE. Peripheral pulmonary artery pseudoaneurysms and massive hemoptysis. AJR Am J Roentgenol 2005; 184:12531259.
  21. Swanson KL, Johnson CM, Prakash UB, McKusick MA, Andrews JC, Stanson AW. Bronchial artery embolization: experience with 54 patients. Chest 2002; 121:789795.
  22. Yoon W, Kim YH, Kim JK, Kim YC, Park JG, Kang HK. Massive hemoptysis: prediction of nonbronchial systemic arterial supply with chest CT. Radiology 2003; 227:232238.
References
  1. Andersen PE. Imaging and interventional radiological treatment of hemoptysis. Acta Radiologica 2006; 47:780792.
  2. Corder R. Hemoptysis. Emerg Med Clin North Am 2003; 21:421435.
  3. Valipour A, Kreuzer A, Koller H, Koessler W, Burghuber OC. Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis. Chest 2005; 127:21132118.
  4. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med 2004; 25:583592.
  5. Khalil A, Soussan M, Mangiapan G, Fartoukh M, Parrot A, Carette MF. Utility of high-resolution chest CT scan in the emergency management of haemoptysis in the intensive care unit: severity, localization and aetiology. Br J Radiol 2007; 80:2125.
  6. Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics 2002; 22:13951409.
  7. Johnson JL. Manifestations of hemoptysis. How to manage minor, moderate, and massive bleeding. Postgrad Med 2002; 112 4:101113.
  8. Bidwell JL, Pachner RW. Hemoptysis: diagnosis and management. Am Fam Phys 2005; 72:12531260.
  9. Bruzzi JF, Remy-Jardin M, Delhaye D, Teisseire A, Khalil C, Remy J. Multi-detector row CT of hemoptysis. Radiographics 2006; 26:322.
  10. Ozgul MA, Turna A, Yildiz P, Ertan E, Kahraman S, Yilmaz V. Risk factors and recurrence patterns in 203 patients with hemoptysis. Tuberk Toraks 2006; 54:243248.
  11. Khalil A, Fartoukh M, Tassart M, Parrot A, Marsault C, Carette MF. Role of MDCT in identification of the bleeding site and the vessels causing hemoptysis. AJR Am J Roentgenol 2007; 188:W117W125.
  12. Remy-Jardin M, Bouaziz N, Dumont P, Brillet PY, Bruzzi J, Remy J. Bronchial and nonbronchial systemic arteries at multi-detector row CT angiography: comparison with conventional angiography. Radiology 2004; 233:741749.
  13. Yoon YC, Lee KS, Jeong YJ, Shin SW, Chung MJ, Kwon OJ. Hemoptysis: bronchial and nonbronchial systemic arteries at 16-detector row CT. Radiology 2005; 234:292298.
  14. Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest 2001; 120:15921594.
  15. Naidich DP, Funt S, Ettenger NA, Arranda C. Hemoptysis: CT-bronchoscopic correlations in 58 cases. Radiology 1990; 177:357362.
  16. McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 1994; 105:11551162.
  17. Revel MP, Fournier LS, Hennebicque AS, et al. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol 2002; 179:12171224.
  18. Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol 2001; 177:861867.
  19. Raoof S, Mehrishi S, Prakash UB. Role of bronchoscopy in modern medical intensive care unit. Clin Chest Med 2001; 22:241261.
  20. Sbano H, Mitchell AW, Ind PW, Jackson JE. Peripheral pulmonary artery pseudoaneurysms and massive hemoptysis. AJR Am J Roentgenol 2005; 184:12531259.
  21. Swanson KL, Johnson CM, Prakash UB, McKusick MA, Andrews JC, Stanson AW. Bronchial artery embolization: experience with 54 patients. Chest 2002; 121:789795.
  22. Yoon W, Kim YH, Kim JK, Kim YC, Park JG, Kang HK. Massive hemoptysis: prediction of nonbronchial systemic arterial supply with chest CT. Radiology 2003; 227:232238.
Issue
Cleveland Clinic Journal of Medicine - 75(8)
Issue
Cleveland Clinic Journal of Medicine - 75(8)
Page Number
601-607
Page Number
601-607
Publications
Publications
Topics
Article Type
Display Headline
A 44-year-old man with hemoptysis: A review of pertinent imaging studies and radiographic interventions
Display Headline
A 44-year-old man with hemoptysis: A review of pertinent imaging studies and radiographic interventions
Sections
Inside the Article

KEY POINTS

  • We recommend chest radiography in the initial stages of evaluation of hemoptysis, whether the hemoptysis is massive or nonmassive.
  • In cases of hemoptysis that is intermittent (whether massive or nonmassive) in patients whose condition is stable, CT, multidetector CT angiography, and bronchoscopy are all useful.
  • In cases of hemoptysis that is active, persistent, and massive, multidetector CT angiography, bronchoscopy, and conventional bronchial angiography are all useful, depending on the hemodynamic stability of the patient.
  • Bronchial artery embolization is the preferred noninvasive first-line treatment for hemoptysis and offers an excellent alternative to surgery for patients who are poor candidates for surgery.
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Identifying serious causes of back pain: Cancer, infection, fracture

Article Type
Changed
Display Headline
Identifying serious causes of back pain: Cancer, infection, fracture

Back pain is one of the most common complaints that internists and primary care physicians encounter.1 Although back pain is nonspecific, some hallmark signs and symptoms indicate that a patient is more likely to have a serious disorder. This article contrasts the presentation of cancer, infections, and fractures with the more common and benign conditions that cause back pain and provides guidance for diagnosis.

UNCOMMON, BUT MUST BE CONSIDERED

Although a variety of tissues can contribute to pain—intervertebral disks, vertebrae, ligaments, neural structures, muscles, and fascia—and many disorders can damage these tissues, most patients with back or neck pain have a benign condition. Back pain is typically caused by age-related degenerative changes or by minor repetitive trauma; with supportive care and physical therapy, up to 90% of patients with back pain of this nature improve substantially within 4 weeks.2

Serious, destructive diseases are uncommon causes of back pain: malignancy, infection, ankylosing spondylitis, and epidural abscess together account for fewer than 1% of cases of back pain in a typical primary care practice. But their clinical impact is out of proportion to their prevalence. The fear of overlooking a serious condition influences any practitioner’s approach to back pain and is a common reason for ordering multiple imaging studies and consultations.3 Therefore, the time, effort, and resources invested in ruling out these disorders is considerable.

Whether a patient with back pain has an ominous disease can usually be determined with a careful history, physical examination, and appropriate diagnostic studies. Once a serious diagnosis is ruled out, attention can be focused on rehabilitation and back care.

Back pain can also be due to musculoskeletal disorders, peptic ulcers, pancreatitis, pyelonephritis, aortic aneurysms, and other serious conditions, which we have discussed in other articles in this journal.4–6

SPINAL CANCER AND METASTASES

Since back pain is the presenting symptom in 90% of patients with spinal tumors,7 neoplasia belongs in the differential diagnosis of any patient with persistent, unremitting back pain. However, it is also important to recognize atypical presentations of neoplasia, such as a painless neurologic deficit, which should prompt an urgent workup.

The spine is one of the most common sites of metastasis: about 20,000 cases arise each year.8 Brihaye et al9 reviewed 1,477 cases of spinal metastases with epidural involvement and found that 16.5% arose from primary tumors in the breast, 15.6% from the lung, 9.2% from the prostate, and 6.5% from the kidney.

Cancer pain is persistent and progressive

Pain from spinal cancer is often different from idiopathic back pain or degenerative disk disease (Table 1).

Benign back pain often arises from a known injury, is relieved by rest, and increases with activities that load the disk (eg, sitting, getting up from bed or a chair), lumbar flexion with or without rotation, lifting, vibration (eg, riding in a car), coughing, sneezing, laughing, and the Valsalva maneuver. It is most commonly focal to the lumbosacral junction, the lumbar muscles, and the buttocks. Pain due to injury or a flare-up of degenerative disease typically begins to subside after 4 to 6 weeks and responds to nonsteroidal anti-inflammatory drugs and physical therapy.10

In contrast, pain caused by spinal neoplasia is typically persistent and progressive and is not alleviated by rest. Often the pain is worse at night, waking the patient from sleep. Back pain is typically focal to the level of the lesion and may be associated with belt-like thoracic pain or radicular symptoms of pain or weakness in the legs. A spinal mass can cause neurologic signs or symptoms by directly compressing the spinal cord or nerve roots, mimicking disk herniation or stenosis.11,12

Pathologic fractures resulting from vertebral destruction may be the first—and unfortunately a late—presentation of a tumor.

Ask about, look for, signs and symptoms of cancer

In taking the history, one should ask about possible signs and symptoms of systemic disease such as fatigue, weight loss, and changes in bowel habits. Hemoptysis, lymphadenopathy, subcutaneous or breast masses, nipple discharge, atypical vaginal bleeding, or blood in the stool suggest malignancy and should direct the specific diagnostic approach.13 A history of cancer, even if remote, should raise suspicion, as should major risk factors such as smoking.

Because most spinal tumors are metastases, a clinical examination of the breast, lungs, abdomen, thyroid, and prostate are appropriate starting points.14 The spine should be examined to identify sites of focal pain. A neurologic examination should be done to evaluate any signs of neurologic compromise or abnormal reflexes. Signs or symptoms of spinal cord compression should be investigated immediately.

 

 

Cancer usually elevates the ESR, CRP

If cancer is suspected, initial tests should include a complete blood cell count, erythrocyte sedimentation rate, C-reactive protein level, urinalysis, prostate-specific antigen level, and fecal occult blood testing. Normal results can considerably relieve suspicion of cancer: the erythrocyte sedimentation rate and C-reactive protein level are almost always elevated with systemic neoplasia.

Figure 1. A 43-year-old man with a 2-week history of progressive back pain and an abdominal mass. Sagittal CT scan shows an osteolytic lesion of the L3 vertebral body (arrow). The primary tumor was renal. Fracture of the vertebral end plate (arrowheads) may cause first symptoms of pain.
Other initial tests include a complete blood cell count and chemistry panel. If laboratory studies reveal anemia, hypercalcemia, and elevated levels of alkaline phosphatase, concern should increase. Chest radiography, abdominal computed tomography (CT) (Figure 1), and mammography for women are needed if laboratory results are abnormal. Plain radiographs are the first imaging study of the spine to obtain. Compression fractures, soft tissue calcifications, or focal loss of bone mineralization suggests tumor. Abnormal results on serum and urine protein electrophoresis increase the likelihood of multiple myeloma or plasmacytoma, but normal results do not rule out monoclonal gammopathy of uncertain significance.

Imaging tests

Unfortunately, spinal tumors cannot be well visualized on radiographs until significant destruction has occurred.15

A bone scan can usually detect tumors other than the purely lytic ones such as myeloma and has a sensitivity of 74%, a specificity of 81%, and a positive predictive value of 64% for vertebral metastasis in patients with back pain.16

Figure 2. A 63-year-old woman with history of hepatocellular carcinoma who presented with bilateral leg weakness and debilitating back pain. T2-weighted MRI shows pathologic compression fracture of the L2 vertebral body with retropulsion of fracture fragments into the canal and severe central canal stenosis (arrow).
Magnetic resonance imaging (MRI) is the best imaging study for evaluating spinal tumors because it can show the status of the bone marrow and has excellent contrast resolution in soft tissue (Figure 2).17,18 It can show vertebral bone marrow infiltration by tumor cells as well as soft tissue masses in and around the spinal column. Bone marrow invaded by a neoplasm is characterized by increased cellularity, resulting in a decreased signal on T1-weighted images and a high signal on T2-weighted images. Intravenous gadolinium further increases the contrast between a tumor and normal tissues and is important for characterizing and grading tumors.19

INFECTION CAN BE INDOLENT OR ACUTE

Spinal infection is a serious condition that can take an indolent, smoldering course or, alternatively, can erupt into sepsis or rapidly progressive vertebral destruction. Although the latter conditions are hard to miss, early diskitis and osteomyelitis can be difficult to differentiate from idiopathic back pain. In a series of 101 patients with vertebral osteomyelitis, misdiagnosis occurred in 33.7%, and the average delay from the onset of clinical manifestations to diagnosis was 2.6 months.20 Tuberculosis can be even more elusive: in a series of 78 patients diagnosed with definite or probable tuberculous vertebral osteomyelitis, the mean delay to diagnosis was about 6 months.21

Acute spinal infections are most often pyogenic; chronic infections may be pyogenic, fungal, or granulomatous.

Vertebral osteomyelitis accounts for 2% to 7% of all cases of osteomyelitis and is an uncommon cause of back pain.22 Any source of infection (eg, dental abscess, pneumonia) can seed the spine; urinary tract infection is the most common. Patients with immunocompromise or diabetes are most at risk.23 The onset is usually insidious with focal back pain at the level of involvement.

History and physical examination reveal localized pain

Spinal infections typically cause pain that is worsened with weight-bearing and activity and is relieved only when lying down. Chronic infection is usually associated with weight loss, fatigue, fevers, and night sweats.

Pain is usually well localized and reproduced by palpation or percussion over the involved level. Severe pain can sometimes be elicited by sitting the patient up or by changing the patient’s position. Focal kyphosis may be detectable if the vertebra has collapsed.

In a series of 41 patients with pyogenic infectious spondylitis, 90% had localized back pain aggravated by percussion, 59% had radicular signs and symptoms, and 29% had neurologic signs of spinal cord compression, including hyperreflexia, clonus, the Babinski sign (extension of the toes upward when the sole of the foot is stroked upwards), or the Hoffmann sign (flexion of the thumb elicited by flicking the end of a middle finger).24

LABORATORY RESULTS TYPICALLY INDICATE INFECTION

The erythrocyte sedimentation rate is the most sensitive test for infection, and an elevated rate may be the only abnormal laboratory finding: Digby and Kersley25 found that the rate was increased in all of 30 patients with nontuberculous pyogenic osteomyelitis of the spine. The C-reactive protein level is also usually elevated, but 40% of patients have a normal white blood cell count.25 Results of other laboratory tests are typically in the normal range. Tuberculin skin testing should be done for patients at high risk of the disease (eg, immigrants from areas of endemic disease, non-Hispanic blacks, immunocompromised patients, and those with known exposure to tuberculosis). Patients with high fever, chills, or rigors should have cultures taken of blood, urine, and sputum and from any intravenous lines.

Imaging changes may not appear for months

Figure 3. A 32-year-old woman with systemic lupus erythematosus who is on chronic steroid therapy and who has a 6-week history of back pain. T2-weighted sagittal MRI shows a disk space infection at L2–L3, with ventral paraspinal soft tissue enhancement consistent with early abscess formation (arrows).
Radiographic findings characteristic of osteomyelitis are not apparent for at least 4 to 8 weeks after the onset of infection.26 Narrowing of the disk space is the earliest and most consistent finding but is nonspecific.27 Pyogenic infection is often heralded by rapid disk destruction and disk space narrowing. MRI is as accurate and sensitive as nuclear medicine scanning (sensitivity 96%, specificity 93%, accuracy 94%).28 MRI can help differentiate degenerative and neoplastic disease from vertebral osteomyelitis29 and provides better imaging than CT for soft-tissue infections (Figure 3).

CT, on the other hand, may be better for showing the extent of bone involvement. In cases of vertebral osteomyelitis and intervertebral disk space infection, simultaneous involvement of the adjacent vertebral end plates and the intervertebral disk are the major findings.30

Signs of infection using T1-weighted MRI include low-signal marrow or disk spaces within the vertebral body, loss of definition of end plates (which appear hypointense compared with the bone marrow), and destruction of the cortical margins of the involved vertebral bodies. T2-weighted MRI typically discloses high signals of the affected areas of the vertebral body and disk. Contrast should be used to increase specificity; enhancement may be the first sign of an acute inflammatory process.31

CT and MRI can help identify sequestra, perilesional sclerosis, and epidural or soft tissue abscesses. Guided biopsy may be needed to differentiate between abscess, hematoma, tumor, and inflammation.

 

 

MRI findings: Pyogenic vs tuberculous spondylitis

MRI can help differentiate pyogenic vertebral osteomyelitis from tubercular disease, although findings may be similar (eg, both conditions have a high signal on T2-weighted images).32 Jung et al,33 in a retrospective study of 52 patients with spondylitis, found that compared with patients with pyogenic infections, patients with tuberculous spondylitis had a significantly higher incidence of a well-defined paraspinal abnormal signal on MRI, a thin and smooth abscess wall, a paraspinal or intraosseous abscess, subligamentous spread to three or more vertebral levels, involvement of multiple vertebral bodies, thoracic spine involvement, and a hyperintense signal on T2-weighted images. Other MRI features characteristically seen in patients with tuberculous spinal disease are anterior corner destruction, a relative preservation of the intervertebral disk, and large soft-tissue abscesses with calcifications.34

Prompt diagnosis and aggressive treatment needed

Pigrau et al35 found that spinal osteomyelitis is highly associated with endocarditis: among 606 patients with infectious endocarditis, 28 (4.6%) had pyogenic vertebral osteomyelitis, and among 91 patients with pyogenic vertebral osteomyelitis, 28 (30.8%) had infectious endocarditis.

McHenry et al36 retrospectively studied outcomes of 253 patients with vertebral osteomyelitis after a median of 6.5 years (range 2 days to 38 years): 11% died, more than one-third of survivors had residual disability, and 14% had a relapse. Surgery resulted in recovery or improvement in 86 (79%) of 109 patients. Independent risk factors for adverse outcome (death or incomplete recovery) were neurologic compromise, increased time to diagnosis, and having a hospital-acquired infection (P = .004). Relapse commonly developed in patients with severe vertebral destruction and abscesses, which appeared some time after surgical drainage or debridement. Recurrent bacteremia, paravertebral abscesses, and chronically draining sinuses were independently associated with relapse (P = .001). MRI, done in 110 patients, was often performed late in the course of infection and did not significantly affect outcome. The authors stressed that an optimal outcome of vertebral osteomyelitis requires heightened awareness, early diagnosis, prompt identification of pathogens, reversal of complications, and prolonged antimicrobial therapy.

Epidural abscess may also be present

Epidural abscess occurs in 10% of spine infections. About half of patients with an epidural abscess are misdiagnosed on their initial evaluation.37,38 Patients initially complain of local spine pain, followed by radicular pain, weakness, and finally paralysis. Between 12% and 30% of patients report a history of trauma, even as minor as a fall, preceding the infection.38,39

Radiologic findings are frequently equivocal, and MRI is preferred; gadolinium enhancement further increases sensitivity.39,40 Spinal canal abscesses usually appear hypointense on T1-weighted images and hyperintense on T2-weighted images, with ring enhancement surrounding the abscess area in contrast studies.41 MRI may give negative findings in the early stages of a spinal canal infection and so may need to be repeated.41 MRI may not help distinguish an epidural from a subdural abscess. However, primary spinal epidural abscesses without concomitant vertebral osteomyelitis are rare; therefore, the finding of associated vertebral osteomyelitis makes a spinal epidural abscess more likely.

FRACTURES

Fractures of the spine can be asymptomatic and may have no preceding trauma. They can be due to osteoporosis, malignancy, infection, or metabolic disorders such as renal osteodystrophy or hyperparathyroidism. Fractures in normal bone are almost always associated with trauma. Any suspicion of infection or malignancy should be investigated.

Corticosteroids increase risk

Any patient with back pain who is receiving corticosteroid therapy should be considered as having a compression fracture until proven otherwise.3 De Vries et al42 found that in a database of nearly 200,000 patients receiving glucocorticoids, risk increased substantially with increasing cumulative exposure. Those who intermittently received high doses (= 15 mg/day) and those who had no or little previous exposure to corticosteroids (cumulative exposure = 1 g) had only a slightly increased risk of osteoporotic fracture, and their risk of fracture of the hip and femur was not increased. In contrast, patients who received a daily dose of at least 30 mg and whose cumulative exposure was more than 5 g had a relative risk of osteoporotic vertebral fracture of 14.42 (95% confidence interval 8.29–25.08).

Osteoporotic compression fractures are common in the elderly

Osteoporosis involves reduced bone density, disrupted trabecular architecture, and increased susceptibility to fractures. About 700,000 vertebral body compression fractures occur in the United States each year43: about 10% result in hospitalization, involving an average stay of 8 days.44 Osteoporotic compression fractures are highly associated with age older than 65, female sex, and European descent.45,46 The estimated lifetime risk of a clinically evident vertebral fracture after age 50 years is 16% among postmenopausal white women and 5% among white men.47

A single osteoporotic vertebral compression fracture increases the risk of subsequent fractures by a factor of five, and up to 20% of patients with a vertebral compression fracture are likely to have another one within the same year if osteoporosis remains untreated.48 Population studies suggest that the death rate among patients who have osteoporotic vertebral compression fractures increases with the number of involved vertebrae.43

Unfortunately, osteoporotic vertebral compression fractures are not always easily amenable to treatment: up to 30% of patients who are symptomatic and seek treatment do not respond adequately to nonsurgical methods.49,50 However, new minimally invasive interventions such as vertebral augmentation make timely evaluation clinically relevant.

 

 

History, physical examination

Patients may present with a history of trauma with associated back pain or a neurologic deficit. In osteoporotic patients, the trauma may have been minimal, eg, a sneeze, a fall from a chair, or a slip and fall in the home. Pain tends to be worse when standing erect and occasionally when lying flat.

The patient is commonly visibly uncomfortable and may be limited to a wheelchair or stoop forward when standing. The spine may show an absence of the midline crease or an exaggerated thoracic kyphosis. Pain is typically reproduced by deep pressure over the spinous process at the involved level. Compression fractures rarely cause neurologic deficits but should always be considered.

Fractures commonly occur in the thoracolumbar region but may be anywhere in the spine. Fractures in the upper thoracic spine may indicate an underlying malignant tumor, and a thorough search for a possible primary lesion should always be carried out for fractures in this location.

Laboratory testing

Routine laboratory evaluation and thyroid function tests should be done, as well as a 24-hour urine specimen for collagen breakdown products, calcium, phosphate, and creatinine levels. Serum and urine protein electrophoresis should be performed if myeloma is suspected. A white blood-cell count, erythrocyte sedimentation rate, and C-reactive protein level help determine if an underlying infection caused the fracture.

MRI needed if plain films reveal fracture or are equivocal

Anteroposterior and lateral roentgenograms should be taken first; they typically show osteopenia. A fracture in the vertebral body is characterized by loss of height and by wedging. Osseous fragments can occasionally be seen in the spinal canal.

If a fracture is diagnosed or the radiographs are equivocal, MRI of the spine should be done next, since it is probably best for determining fracture age, detecting a malignant tumor (Table 2), and helping select appropriate treatment. Shortly after a vertebral fracture, MRI shows a geographic pattern of low-intensity signal changes on T1-weighted images and high-intensity signal changes on T2-weighted images. As a fracture becomes chronic, a linear area of low-intensity signal change replaces the geographic area on T1-weighted images. As healing continues, the linear pattern is replaced by restoration of fatty marrow.51

Sagittal short tau inversion recovery sequences, which use specifically timed pulse sequences to suppress fat signals, show high-intensity signal changes in areas of edema from acute or healing fractures. They provide a sensitive but nonspecific marker of abnormality.

Dual energy x-ray absorptiometry helps determine the extent of osteoporosis.

Bone scans should only be used for patients with suspected metastatic disease.

Patients with ankylosing spondylitis need thorough workup

Ankylosing spondylitis predisposes to serious spinal injury. Even after only minor trauma, patients with ankylosing spondylitis and acute, severe back pain should be thoroughly evaluated for fracture with CT and MRI of the entire spine. Plain radiography should not be relied on for these patients because of the risk of misinterpretation, delayed diagnosis, and poorer outcomes.52,53

NEUROLOGIC COMPROMISE—A RED FLAG

Neural compromise can result from spinal cord or cauda equina compression (Table 3). Cauda equina compression usually results from a fracture, tumor, epidural hematoma, or abscess, and occasionally from massive disk herniation. Paraplegia, quadriplegia, or cauda equina deficit should trigger an aggressive search for the cause.54

Cauda equina compression classically presents with back pain, bilateral sciatica, saddle anesthesia, and lower extremity weakness progressing to paraplegia, but in practice these symptoms are variably present and diagnosing the condition often requires a high degree of suspicion. Hyporeflexia is typically a sign of cauda equina compression, while hyperreflexia, clonus, and the Babinski sign suggest spinal cord compression, requiring an evaluation of the cervical and thoracic spine. Cauda equina compression typically involves urinary retention; in contrast, cord compression typically causes incontinence.55

If either cauda equina or spinal cord compression is detected during an initial examination, an immediate more extensive evaluation is warranted. MRI is the study of choice.

Spinal epidural hematoma

Spinal epidural hematoma is a rare but dramatic cause of paralysis in elderly patients. In most cases, there is no antecedent trauma. Lawton et al,56 in a series of 30 patients treated surgically for spinal epidural hematoma, found that 73% resulted from spine surgery, epidural catheterization, or anticoagulation therapy. Other possible causes of epidural hematoma include vascular malformations, angiomas, aneurysms, hypertension, and aspirin therapy.57

The same study56 found that the time from the first symptom to maximal neurologic deficit ranged from a few minutes to 4 days, with the average interval being nearly 13 hours.

Although painless onset has been reported,58 spinal epidural hematoma typically presents with acute pain at the level of the lesion, which is often rapidly followed by paraplegia or quadriplegia, depending on the location of the hemorrhage. Sometimes the onset of pain is preceded by a sudden increase of venous pressure from coughing, sneezing, or straining at stool. Urinary retention often develops at an early stage.

Most lesions occur in the thoracic region and extend into the cervicothoracic or the thoracolumbar area. The pain distribution may be radicular, mimicking a ruptured intervertebral disk.

Evaluation should be with MRI. Acute hemorrhage is characterized by a marked decrease in signal intensity on T2-weighted images. Subacute hematoma has increased signal intensity on both T1- and T2-weighted images.56

Early recognition, MRI confirmation, and treatment should be accomplished as soon as possible.56 Recovery depends on the severity of the neurologic deficit and the duration of symptoms before treatment. Lawton et al56 found that patients taken to surgery within 12 hours had better neurologic outcomes than patients with identical preoperative neurologic status whose surgery was delayed beyond 12 hours. Surgery should not be withheld because of advanced age or poor health: in 10 reported cases in which surgery was delayed, all patients died.59

References
  1. Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine 1987; 12:264268.
  2. Pengel LH, Herbert RD, Maher CG, Refshauge KM. Acute back pain: systematic review of its prognosis. BMJ 2003; 327:323325.
  3. Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about back pain? JAMA 1992; 268:760765.
  4. Pateder DB, Brems J, Lieberman I, Bell GR, McLain RF. Masquerade: nonspinal musculoskeletal disorders that mimic spinal conditions. Cleve Clin J Med 2008; 75:5056.
  5. Klineberg E, Mazanec D, Orr D, Demicco R, Bell G, McLain R. Masquerade: medical causes of back pain. Cleve Clin J Med 2007; 74:905913.
  6. McLain RF, Bell G, Montgomery W. Masquerade: systemic causes of back pain. Cleve Clin J Med In press.
  7. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978; 3:4051.
  8. Black P. Spinal metastasis: current status and recommended guidelines for management. Neurosurgery 1979; 5:726746.
  9. Brihaye J, Ectors P, Lemort M, Van Houtte P. The management of spinal epidural metastases. Adv Tech Stand Neurosurg 1988; 16:121176.
  10. Patel RK, Slipman CW. Lumbar degenerative disk disease. Emedicine. Accessed March 25, 2008. http://www.emedicine.com/pmr/topic67.htm.
  11. Deyo RA, Diehl AK. Cancer as a cause of back pain: frequency, clinical presentation, and diagnostic strategies. J Gen Intern Med 1988; 3:230238.
  12. Rosen P, Barkin RM, Danzl DF, et al. Emergency Medicine: Concepts and Clinical Practice. 4th ed. St Louis, MO: Mosby; 1998:21002102.
  13. Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 1995; 13:20942103.
  14. McCarthy EF, Frassica FJ. Pathology of Bone and Joint Disorders: With Clinical and Radiographic Correlation. Philadelphia: WB Saunders; 1998.
  15. Edelstyn GA, Gillespie PJ, Grebbell FS. The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol 1967; 18:158162.
  16. Han LJ, Au-Yong TK, Tong WC, Chu KS, Szeto LT, Wong CP. Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain. Eur J Nucl Med 1998; 25:635638.
  17. Feun LG, Savaraj N. Detection of occult bone metastasis by MRI scan. J Fla Med Assoc 1990; 77:881883.
  18. Citrin DL, Bessent RG, Greig WR. A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol 1977; 28:107117.
  19. Runge VM, Lee C, Iten AL, Williams NM. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model. Invest Radiol 1997; 32:589595.
  20. Buranapanitkit B, Lim A, Geater A. Misdiagnosis in vertebral osteomyelitis: problems and factors. J Med Assoc Thai 2001; 84:17431750.
  21. Colmenero JD, Jiménez-Mejías ME, Reguera JM, et al. Tuberculous vertebral osteomyelitis in the new millennium: still a diagnostic and therapeutic challenge. Eur J Clin Microbiol Infect Dis 2004; 23:477483.
  22. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N Engl J Med 1970; 282:316322.
  23. Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am 1997; 79:874880.
  24. Kapeller P, Fazekas F, Krametter D, et al. Pyogenic infectious spondylitis: clinical, laboratory and MRI features. Eur Neurol 1997; 38:9498.
  25. Digby JM, Kersley JB. Pyogenic non-tuberculous spinal infection: an analysis of thirty cases. J Bone Joint Surg Br 1979; 61:4755.
  26. Modic MT, Feiglin DH, Piraino DW, et al. Vertebral osteomyelitis: assessment using MR. Radiology 1985; 157:157166.
  27. Szypryt EP, Hardy JG, Hinton CE, Worthington BS, Mulholland RC. A comparison between magnetic resonance imaging and scintigraphic bone imaging in the diagnosis of disk space infection in an animal model. Spine 1988; 13:10421048.
  28. Küker W, Mull M, Mayfrank L, Töpper R, Thron A. Epidural spinal infection. Variability of clinical and magnetic resonance imaging findings. Spine 1997; 22:544551.
  29. Tung GA, Yim JW, Mermel LA, Philip L, Rogg JM. Spinal epidural abscess: correlation between MRI findings and outcome. Neuroradiology 1999; 41:904909.
  30. Sapico FL, Montgomerie JZ. Vertebral osteomyelitis. Infect Dis Clin North Am 1990; 4:539550.
  31. Tali ET. Spinal infections. Eur J Radiol 2004; 50:120133.
  32. Smith AS, Weinstein MA, Mizushima A, et al. MR imaging characteristics of tuberculous spondylitis vs vertebral osteomyelitis. AJR Am J Roentgenol 1989; 153:399405.
  33. Jung NY, Jee WH, Ha KY, Park CK, Byun JY. Discrimination of tuberculous spondylitis from pyogenic spondylitis on MRI. AJR Am J Roentgenol 2004; 182:14051410.
  34. Joseffer SS, Cooper PR. Modern imaging of spinal tuberculosis. J Neurosurg Spine 2005; 2:145150.
  35. Pigrau C, Almirante B, Flores X, et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. Am J Med 2005; 118:1287.
  36. McHenry MC, Easley KA, Locker GA. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis 2002; 34:13421350.
  37. Danner RL, Hartman BJ. Update on spinal epidural abscess: 35 cases and review of the literature. Rev Infect Dis 1987; 9:265274.
  38. Kaufman DM, Kaplan JG, Litman N. Infectious agents in spinal epidural abscesses. Neurology 1980; 30:844850.
  39. Rezai AR, Woo HH, Errico TJ, Cooper PR. Contemporary management of spinal osteomyelitis. Neurosurgery 1999; 44:10181026.
  40. Bertino RE, Porter BA, Stimac GK, Tepper SJ. Imaging spinal osteomyelitis and epidural abscess with short TI inversion recovery (STIR). AJNR Am J Neuroradiol 1988; 9:563564.
  41. Rigamonti D, Liem L, Sampath P, et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol 1999; 52:189197.
  42. De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 2007; 56:208214.
  43. Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 1992; 7:221227.
  44. Kim DH, Vaccaro AR. Osteoporotic compression fractures of the spine; current options and considerations for treatment. Spine J 2006; 6:479487.
  45. Cohn SH, Abesamis C, Yasumura S, Aloia JF, Zanzi I, Ellis KJ. Comparative skeletal mass and radial bone mineral content in black and white women. Metabolism 1977; 26:171178.
  46. Tobias JH, Hutchinson AP, Hunt LP, et al. Use of clinical risk factors to identify postmenopausal women with vertebral fractures. Osteoporos Int 2007; 18:3543.
  47. Melton LJ, Kallmes DF. Epidemiology of vertebral fractures: implications for vertebral augmentation. Acad Radiol 2006; 13:538545.
  48. Silverman SL. The clinical consequences of vertebral compression fracture. Bone 1992; 13:S27S31.
  49. Melton LJ, Kan SH, Frye MA, Wahner HW, O’Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989; 129:10001011.
  50. Wasnich RD. Vertebral fracture epidemiology. Bone 1996; 18:179S183S.
  51. Yamato M, Nishimura G, Kuramochi E, Saiki N, Fujioka M. MR appearance at different ages of osteoporotic compression fractures of the vertebrae. Radiat Med 1998; 16:329334.
  52. Einsiedel T, Schmelz A, Arand M, et al. Injuries of the cervical spine in patients with ankylosing spondylitis: experience at two trauma centers. J Neurosurg Spine 2006; 5:3345.
  53. Olerud C, Frost A, Bring J. Spinal fractures in patients with ankylosing spondylitis. Eur Spine J 1996; 5:5155.
  54. Spangfort EV. The lumbar disk herniation. A computer-aided analysis of 2,504 operations. Acta Orthop Scand Suppl 1972; 142:195.
  55. Kostuik JP, Harrington I, Alexander D, Rand W, Evans D. Cauda equina syndrome and lumbar disk herniation. J Bone Joint Surg Am 1986; 68:386391.
  56. Lawton MT, Porter RW, Heiserman JE, Jacobowitz R, Sonntag VK, Dickman CA. Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome. J Neurosurg 1995; 83:17.
  57. Simmons EH, Grobler LJ. Acute spinal epidural hematoma. J Bone Joint Surg Am 1978; 60:395396.
  58. Senelick RC, Norwood CW, Cohen GH. “Painless” spinal epidural hematoma during anticoagulant therapy”. Neurology 1976; 26:213225.
  59. Watts C, Porto L. Recognizing spontaneous spinal epidural hematoma. Geriatrics 1976; 31:9799.
Article PDF
Author and Disclosure Information

Krzysztof Siemionow, MD
Department of Orthopaedic Surgery, Cleveland Clinic

Michael Steinmetz, MD
Department of Neurosurgery, and Cleveland Clinic Center for Spine Health, Cleveland Clinic

Gordon Bell, MD
Vice-Chairman, Department of Orthopaedic Surgery, and Associate Director, Cleveland Clinic Center for Spine Health, Cleveland Clinic

Hakan Ilaslan, MD
Department of Radiology, Cleveland Clinic

Robert F. McLain, MD
Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Director of Spine Fellowship Program, Department of Orthopaedic Surgery and Cleveland Clinic Center for Spine Health, Cleveland Clinic

Address: Robert F. McLain, MD, Cleveland Clinic Center for Spine Health, Department of Orthopaedic Surgery, A41, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 75(8)
Publications
Topics
Page Number
557-566
Sections
Author and Disclosure Information

Krzysztof Siemionow, MD
Department of Orthopaedic Surgery, Cleveland Clinic

Michael Steinmetz, MD
Department of Neurosurgery, and Cleveland Clinic Center for Spine Health, Cleveland Clinic

Gordon Bell, MD
Vice-Chairman, Department of Orthopaedic Surgery, and Associate Director, Cleveland Clinic Center for Spine Health, Cleveland Clinic

Hakan Ilaslan, MD
Department of Radiology, Cleveland Clinic

Robert F. McLain, MD
Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Director of Spine Fellowship Program, Department of Orthopaedic Surgery and Cleveland Clinic Center for Spine Health, Cleveland Clinic

Address: Robert F. McLain, MD, Cleveland Clinic Center for Spine Health, Department of Orthopaedic Surgery, A41, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Krzysztof Siemionow, MD
Department of Orthopaedic Surgery, Cleveland Clinic

Michael Steinmetz, MD
Department of Neurosurgery, and Cleveland Clinic Center for Spine Health, Cleveland Clinic

Gordon Bell, MD
Vice-Chairman, Department of Orthopaedic Surgery, and Associate Director, Cleveland Clinic Center for Spine Health, Cleveland Clinic

Hakan Ilaslan, MD
Department of Radiology, Cleveland Clinic

Robert F. McLain, MD
Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Director of Spine Fellowship Program, Department of Orthopaedic Surgery and Cleveland Clinic Center for Spine Health, Cleveland Clinic

Address: Robert F. McLain, MD, Cleveland Clinic Center for Spine Health, Department of Orthopaedic Surgery, A41, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF

Back pain is one of the most common complaints that internists and primary care physicians encounter.1 Although back pain is nonspecific, some hallmark signs and symptoms indicate that a patient is more likely to have a serious disorder. This article contrasts the presentation of cancer, infections, and fractures with the more common and benign conditions that cause back pain and provides guidance for diagnosis.

UNCOMMON, BUT MUST BE CONSIDERED

Although a variety of tissues can contribute to pain—intervertebral disks, vertebrae, ligaments, neural structures, muscles, and fascia—and many disorders can damage these tissues, most patients with back or neck pain have a benign condition. Back pain is typically caused by age-related degenerative changes or by minor repetitive trauma; with supportive care and physical therapy, up to 90% of patients with back pain of this nature improve substantially within 4 weeks.2

Serious, destructive diseases are uncommon causes of back pain: malignancy, infection, ankylosing spondylitis, and epidural abscess together account for fewer than 1% of cases of back pain in a typical primary care practice. But their clinical impact is out of proportion to their prevalence. The fear of overlooking a serious condition influences any practitioner’s approach to back pain and is a common reason for ordering multiple imaging studies and consultations.3 Therefore, the time, effort, and resources invested in ruling out these disorders is considerable.

Whether a patient with back pain has an ominous disease can usually be determined with a careful history, physical examination, and appropriate diagnostic studies. Once a serious diagnosis is ruled out, attention can be focused on rehabilitation and back care.

Back pain can also be due to musculoskeletal disorders, peptic ulcers, pancreatitis, pyelonephritis, aortic aneurysms, and other serious conditions, which we have discussed in other articles in this journal.4–6

SPINAL CANCER AND METASTASES

Since back pain is the presenting symptom in 90% of patients with spinal tumors,7 neoplasia belongs in the differential diagnosis of any patient with persistent, unremitting back pain. However, it is also important to recognize atypical presentations of neoplasia, such as a painless neurologic deficit, which should prompt an urgent workup.

The spine is one of the most common sites of metastasis: about 20,000 cases arise each year.8 Brihaye et al9 reviewed 1,477 cases of spinal metastases with epidural involvement and found that 16.5% arose from primary tumors in the breast, 15.6% from the lung, 9.2% from the prostate, and 6.5% from the kidney.

Cancer pain is persistent and progressive

Pain from spinal cancer is often different from idiopathic back pain or degenerative disk disease (Table 1).

Benign back pain often arises from a known injury, is relieved by rest, and increases with activities that load the disk (eg, sitting, getting up from bed or a chair), lumbar flexion with or without rotation, lifting, vibration (eg, riding in a car), coughing, sneezing, laughing, and the Valsalva maneuver. It is most commonly focal to the lumbosacral junction, the lumbar muscles, and the buttocks. Pain due to injury or a flare-up of degenerative disease typically begins to subside after 4 to 6 weeks and responds to nonsteroidal anti-inflammatory drugs and physical therapy.10

In contrast, pain caused by spinal neoplasia is typically persistent and progressive and is not alleviated by rest. Often the pain is worse at night, waking the patient from sleep. Back pain is typically focal to the level of the lesion and may be associated with belt-like thoracic pain or radicular symptoms of pain or weakness in the legs. A spinal mass can cause neurologic signs or symptoms by directly compressing the spinal cord or nerve roots, mimicking disk herniation or stenosis.11,12

Pathologic fractures resulting from vertebral destruction may be the first—and unfortunately a late—presentation of a tumor.

Ask about, look for, signs and symptoms of cancer

In taking the history, one should ask about possible signs and symptoms of systemic disease such as fatigue, weight loss, and changes in bowel habits. Hemoptysis, lymphadenopathy, subcutaneous or breast masses, nipple discharge, atypical vaginal bleeding, or blood in the stool suggest malignancy and should direct the specific diagnostic approach.13 A history of cancer, even if remote, should raise suspicion, as should major risk factors such as smoking.

Because most spinal tumors are metastases, a clinical examination of the breast, lungs, abdomen, thyroid, and prostate are appropriate starting points.14 The spine should be examined to identify sites of focal pain. A neurologic examination should be done to evaluate any signs of neurologic compromise or abnormal reflexes. Signs or symptoms of spinal cord compression should be investigated immediately.

 

 

Cancer usually elevates the ESR, CRP

If cancer is suspected, initial tests should include a complete blood cell count, erythrocyte sedimentation rate, C-reactive protein level, urinalysis, prostate-specific antigen level, and fecal occult blood testing. Normal results can considerably relieve suspicion of cancer: the erythrocyte sedimentation rate and C-reactive protein level are almost always elevated with systemic neoplasia.

Figure 1. A 43-year-old man with a 2-week history of progressive back pain and an abdominal mass. Sagittal CT scan shows an osteolytic lesion of the L3 vertebral body (arrow). The primary tumor was renal. Fracture of the vertebral end plate (arrowheads) may cause first symptoms of pain.
Other initial tests include a complete blood cell count and chemistry panel. If laboratory studies reveal anemia, hypercalcemia, and elevated levels of alkaline phosphatase, concern should increase. Chest radiography, abdominal computed tomography (CT) (Figure 1), and mammography for women are needed if laboratory results are abnormal. Plain radiographs are the first imaging study of the spine to obtain. Compression fractures, soft tissue calcifications, or focal loss of bone mineralization suggests tumor. Abnormal results on serum and urine protein electrophoresis increase the likelihood of multiple myeloma or plasmacytoma, but normal results do not rule out monoclonal gammopathy of uncertain significance.

Imaging tests

Unfortunately, spinal tumors cannot be well visualized on radiographs until significant destruction has occurred.15

A bone scan can usually detect tumors other than the purely lytic ones such as myeloma and has a sensitivity of 74%, a specificity of 81%, and a positive predictive value of 64% for vertebral metastasis in patients with back pain.16

Figure 2. A 63-year-old woman with history of hepatocellular carcinoma who presented with bilateral leg weakness and debilitating back pain. T2-weighted MRI shows pathologic compression fracture of the L2 vertebral body with retropulsion of fracture fragments into the canal and severe central canal stenosis (arrow).
Magnetic resonance imaging (MRI) is the best imaging study for evaluating spinal tumors because it can show the status of the bone marrow and has excellent contrast resolution in soft tissue (Figure 2).17,18 It can show vertebral bone marrow infiltration by tumor cells as well as soft tissue masses in and around the spinal column. Bone marrow invaded by a neoplasm is characterized by increased cellularity, resulting in a decreased signal on T1-weighted images and a high signal on T2-weighted images. Intravenous gadolinium further increases the contrast between a tumor and normal tissues and is important for characterizing and grading tumors.19

INFECTION CAN BE INDOLENT OR ACUTE

Spinal infection is a serious condition that can take an indolent, smoldering course or, alternatively, can erupt into sepsis or rapidly progressive vertebral destruction. Although the latter conditions are hard to miss, early diskitis and osteomyelitis can be difficult to differentiate from idiopathic back pain. In a series of 101 patients with vertebral osteomyelitis, misdiagnosis occurred in 33.7%, and the average delay from the onset of clinical manifestations to diagnosis was 2.6 months.20 Tuberculosis can be even more elusive: in a series of 78 patients diagnosed with definite or probable tuberculous vertebral osteomyelitis, the mean delay to diagnosis was about 6 months.21

Acute spinal infections are most often pyogenic; chronic infections may be pyogenic, fungal, or granulomatous.

Vertebral osteomyelitis accounts for 2% to 7% of all cases of osteomyelitis and is an uncommon cause of back pain.22 Any source of infection (eg, dental abscess, pneumonia) can seed the spine; urinary tract infection is the most common. Patients with immunocompromise or diabetes are most at risk.23 The onset is usually insidious with focal back pain at the level of involvement.

History and physical examination reveal localized pain

Spinal infections typically cause pain that is worsened with weight-bearing and activity and is relieved only when lying down. Chronic infection is usually associated with weight loss, fatigue, fevers, and night sweats.

Pain is usually well localized and reproduced by palpation or percussion over the involved level. Severe pain can sometimes be elicited by sitting the patient up or by changing the patient’s position. Focal kyphosis may be detectable if the vertebra has collapsed.

In a series of 41 patients with pyogenic infectious spondylitis, 90% had localized back pain aggravated by percussion, 59% had radicular signs and symptoms, and 29% had neurologic signs of spinal cord compression, including hyperreflexia, clonus, the Babinski sign (extension of the toes upward when the sole of the foot is stroked upwards), or the Hoffmann sign (flexion of the thumb elicited by flicking the end of a middle finger).24

LABORATORY RESULTS TYPICALLY INDICATE INFECTION

The erythrocyte sedimentation rate is the most sensitive test for infection, and an elevated rate may be the only abnormal laboratory finding: Digby and Kersley25 found that the rate was increased in all of 30 patients with nontuberculous pyogenic osteomyelitis of the spine. The C-reactive protein level is also usually elevated, but 40% of patients have a normal white blood cell count.25 Results of other laboratory tests are typically in the normal range. Tuberculin skin testing should be done for patients at high risk of the disease (eg, immigrants from areas of endemic disease, non-Hispanic blacks, immunocompromised patients, and those with known exposure to tuberculosis). Patients with high fever, chills, or rigors should have cultures taken of blood, urine, and sputum and from any intravenous lines.

Imaging changes may not appear for months

Figure 3. A 32-year-old woman with systemic lupus erythematosus who is on chronic steroid therapy and who has a 6-week history of back pain. T2-weighted sagittal MRI shows a disk space infection at L2–L3, with ventral paraspinal soft tissue enhancement consistent with early abscess formation (arrows).
Radiographic findings characteristic of osteomyelitis are not apparent for at least 4 to 8 weeks after the onset of infection.26 Narrowing of the disk space is the earliest and most consistent finding but is nonspecific.27 Pyogenic infection is often heralded by rapid disk destruction and disk space narrowing. MRI is as accurate and sensitive as nuclear medicine scanning (sensitivity 96%, specificity 93%, accuracy 94%).28 MRI can help differentiate degenerative and neoplastic disease from vertebral osteomyelitis29 and provides better imaging than CT for soft-tissue infections (Figure 3).

CT, on the other hand, may be better for showing the extent of bone involvement. In cases of vertebral osteomyelitis and intervertebral disk space infection, simultaneous involvement of the adjacent vertebral end plates and the intervertebral disk are the major findings.30

Signs of infection using T1-weighted MRI include low-signal marrow or disk spaces within the vertebral body, loss of definition of end plates (which appear hypointense compared with the bone marrow), and destruction of the cortical margins of the involved vertebral bodies. T2-weighted MRI typically discloses high signals of the affected areas of the vertebral body and disk. Contrast should be used to increase specificity; enhancement may be the first sign of an acute inflammatory process.31

CT and MRI can help identify sequestra, perilesional sclerosis, and epidural or soft tissue abscesses. Guided biopsy may be needed to differentiate between abscess, hematoma, tumor, and inflammation.

 

 

MRI findings: Pyogenic vs tuberculous spondylitis

MRI can help differentiate pyogenic vertebral osteomyelitis from tubercular disease, although findings may be similar (eg, both conditions have a high signal on T2-weighted images).32 Jung et al,33 in a retrospective study of 52 patients with spondylitis, found that compared with patients with pyogenic infections, patients with tuberculous spondylitis had a significantly higher incidence of a well-defined paraspinal abnormal signal on MRI, a thin and smooth abscess wall, a paraspinal or intraosseous abscess, subligamentous spread to three or more vertebral levels, involvement of multiple vertebral bodies, thoracic spine involvement, and a hyperintense signal on T2-weighted images. Other MRI features characteristically seen in patients with tuberculous spinal disease are anterior corner destruction, a relative preservation of the intervertebral disk, and large soft-tissue abscesses with calcifications.34

Prompt diagnosis and aggressive treatment needed

Pigrau et al35 found that spinal osteomyelitis is highly associated with endocarditis: among 606 patients with infectious endocarditis, 28 (4.6%) had pyogenic vertebral osteomyelitis, and among 91 patients with pyogenic vertebral osteomyelitis, 28 (30.8%) had infectious endocarditis.

McHenry et al36 retrospectively studied outcomes of 253 patients with vertebral osteomyelitis after a median of 6.5 years (range 2 days to 38 years): 11% died, more than one-third of survivors had residual disability, and 14% had a relapse. Surgery resulted in recovery or improvement in 86 (79%) of 109 patients. Independent risk factors for adverse outcome (death or incomplete recovery) were neurologic compromise, increased time to diagnosis, and having a hospital-acquired infection (P = .004). Relapse commonly developed in patients with severe vertebral destruction and abscesses, which appeared some time after surgical drainage or debridement. Recurrent bacteremia, paravertebral abscesses, and chronically draining sinuses were independently associated with relapse (P = .001). MRI, done in 110 patients, was often performed late in the course of infection and did not significantly affect outcome. The authors stressed that an optimal outcome of vertebral osteomyelitis requires heightened awareness, early diagnosis, prompt identification of pathogens, reversal of complications, and prolonged antimicrobial therapy.

Epidural abscess may also be present

Epidural abscess occurs in 10% of spine infections. About half of patients with an epidural abscess are misdiagnosed on their initial evaluation.37,38 Patients initially complain of local spine pain, followed by radicular pain, weakness, and finally paralysis. Between 12% and 30% of patients report a history of trauma, even as minor as a fall, preceding the infection.38,39

Radiologic findings are frequently equivocal, and MRI is preferred; gadolinium enhancement further increases sensitivity.39,40 Spinal canal abscesses usually appear hypointense on T1-weighted images and hyperintense on T2-weighted images, with ring enhancement surrounding the abscess area in contrast studies.41 MRI may give negative findings in the early stages of a spinal canal infection and so may need to be repeated.41 MRI may not help distinguish an epidural from a subdural abscess. However, primary spinal epidural abscesses without concomitant vertebral osteomyelitis are rare; therefore, the finding of associated vertebral osteomyelitis makes a spinal epidural abscess more likely.

FRACTURES

Fractures of the spine can be asymptomatic and may have no preceding trauma. They can be due to osteoporosis, malignancy, infection, or metabolic disorders such as renal osteodystrophy or hyperparathyroidism. Fractures in normal bone are almost always associated with trauma. Any suspicion of infection or malignancy should be investigated.

Corticosteroids increase risk

Any patient with back pain who is receiving corticosteroid therapy should be considered as having a compression fracture until proven otherwise.3 De Vries et al42 found that in a database of nearly 200,000 patients receiving glucocorticoids, risk increased substantially with increasing cumulative exposure. Those who intermittently received high doses (= 15 mg/day) and those who had no or little previous exposure to corticosteroids (cumulative exposure = 1 g) had only a slightly increased risk of osteoporotic fracture, and their risk of fracture of the hip and femur was not increased. In contrast, patients who received a daily dose of at least 30 mg and whose cumulative exposure was more than 5 g had a relative risk of osteoporotic vertebral fracture of 14.42 (95% confidence interval 8.29–25.08).

Osteoporotic compression fractures are common in the elderly

Osteoporosis involves reduced bone density, disrupted trabecular architecture, and increased susceptibility to fractures. About 700,000 vertebral body compression fractures occur in the United States each year43: about 10% result in hospitalization, involving an average stay of 8 days.44 Osteoporotic compression fractures are highly associated with age older than 65, female sex, and European descent.45,46 The estimated lifetime risk of a clinically evident vertebral fracture after age 50 years is 16% among postmenopausal white women and 5% among white men.47

A single osteoporotic vertebral compression fracture increases the risk of subsequent fractures by a factor of five, and up to 20% of patients with a vertebral compression fracture are likely to have another one within the same year if osteoporosis remains untreated.48 Population studies suggest that the death rate among patients who have osteoporotic vertebral compression fractures increases with the number of involved vertebrae.43

Unfortunately, osteoporotic vertebral compression fractures are not always easily amenable to treatment: up to 30% of patients who are symptomatic and seek treatment do not respond adequately to nonsurgical methods.49,50 However, new minimally invasive interventions such as vertebral augmentation make timely evaluation clinically relevant.

 

 

History, physical examination

Patients may present with a history of trauma with associated back pain or a neurologic deficit. In osteoporotic patients, the trauma may have been minimal, eg, a sneeze, a fall from a chair, or a slip and fall in the home. Pain tends to be worse when standing erect and occasionally when lying flat.

The patient is commonly visibly uncomfortable and may be limited to a wheelchair or stoop forward when standing. The spine may show an absence of the midline crease or an exaggerated thoracic kyphosis. Pain is typically reproduced by deep pressure over the spinous process at the involved level. Compression fractures rarely cause neurologic deficits but should always be considered.

Fractures commonly occur in the thoracolumbar region but may be anywhere in the spine. Fractures in the upper thoracic spine may indicate an underlying malignant tumor, and a thorough search for a possible primary lesion should always be carried out for fractures in this location.

Laboratory testing

Routine laboratory evaluation and thyroid function tests should be done, as well as a 24-hour urine specimen for collagen breakdown products, calcium, phosphate, and creatinine levels. Serum and urine protein electrophoresis should be performed if myeloma is suspected. A white blood-cell count, erythrocyte sedimentation rate, and C-reactive protein level help determine if an underlying infection caused the fracture.

MRI needed if plain films reveal fracture or are equivocal

Anteroposterior and lateral roentgenograms should be taken first; they typically show osteopenia. A fracture in the vertebral body is characterized by loss of height and by wedging. Osseous fragments can occasionally be seen in the spinal canal.

If a fracture is diagnosed or the radiographs are equivocal, MRI of the spine should be done next, since it is probably best for determining fracture age, detecting a malignant tumor (Table 2), and helping select appropriate treatment. Shortly after a vertebral fracture, MRI shows a geographic pattern of low-intensity signal changes on T1-weighted images and high-intensity signal changes on T2-weighted images. As a fracture becomes chronic, a linear area of low-intensity signal change replaces the geographic area on T1-weighted images. As healing continues, the linear pattern is replaced by restoration of fatty marrow.51

Sagittal short tau inversion recovery sequences, which use specifically timed pulse sequences to suppress fat signals, show high-intensity signal changes in areas of edema from acute or healing fractures. They provide a sensitive but nonspecific marker of abnormality.

Dual energy x-ray absorptiometry helps determine the extent of osteoporosis.

Bone scans should only be used for patients with suspected metastatic disease.

Patients with ankylosing spondylitis need thorough workup

Ankylosing spondylitis predisposes to serious spinal injury. Even after only minor trauma, patients with ankylosing spondylitis and acute, severe back pain should be thoroughly evaluated for fracture with CT and MRI of the entire spine. Plain radiography should not be relied on for these patients because of the risk of misinterpretation, delayed diagnosis, and poorer outcomes.52,53

NEUROLOGIC COMPROMISE—A RED FLAG

Neural compromise can result from spinal cord or cauda equina compression (Table 3). Cauda equina compression usually results from a fracture, tumor, epidural hematoma, or abscess, and occasionally from massive disk herniation. Paraplegia, quadriplegia, or cauda equina deficit should trigger an aggressive search for the cause.54

Cauda equina compression classically presents with back pain, bilateral sciatica, saddle anesthesia, and lower extremity weakness progressing to paraplegia, but in practice these symptoms are variably present and diagnosing the condition often requires a high degree of suspicion. Hyporeflexia is typically a sign of cauda equina compression, while hyperreflexia, clonus, and the Babinski sign suggest spinal cord compression, requiring an evaluation of the cervical and thoracic spine. Cauda equina compression typically involves urinary retention; in contrast, cord compression typically causes incontinence.55

If either cauda equina or spinal cord compression is detected during an initial examination, an immediate more extensive evaluation is warranted. MRI is the study of choice.

Spinal epidural hematoma

Spinal epidural hematoma is a rare but dramatic cause of paralysis in elderly patients. In most cases, there is no antecedent trauma. Lawton et al,56 in a series of 30 patients treated surgically for spinal epidural hematoma, found that 73% resulted from spine surgery, epidural catheterization, or anticoagulation therapy. Other possible causes of epidural hematoma include vascular malformations, angiomas, aneurysms, hypertension, and aspirin therapy.57

The same study56 found that the time from the first symptom to maximal neurologic deficit ranged from a few minutes to 4 days, with the average interval being nearly 13 hours.

Although painless onset has been reported,58 spinal epidural hematoma typically presents with acute pain at the level of the lesion, which is often rapidly followed by paraplegia or quadriplegia, depending on the location of the hemorrhage. Sometimes the onset of pain is preceded by a sudden increase of venous pressure from coughing, sneezing, or straining at stool. Urinary retention often develops at an early stage.

Most lesions occur in the thoracic region and extend into the cervicothoracic or the thoracolumbar area. The pain distribution may be radicular, mimicking a ruptured intervertebral disk.

Evaluation should be with MRI. Acute hemorrhage is characterized by a marked decrease in signal intensity on T2-weighted images. Subacute hematoma has increased signal intensity on both T1- and T2-weighted images.56

Early recognition, MRI confirmation, and treatment should be accomplished as soon as possible.56 Recovery depends on the severity of the neurologic deficit and the duration of symptoms before treatment. Lawton et al56 found that patients taken to surgery within 12 hours had better neurologic outcomes than patients with identical preoperative neurologic status whose surgery was delayed beyond 12 hours. Surgery should not be withheld because of advanced age or poor health: in 10 reported cases in which surgery was delayed, all patients died.59

Back pain is one of the most common complaints that internists and primary care physicians encounter.1 Although back pain is nonspecific, some hallmark signs and symptoms indicate that a patient is more likely to have a serious disorder. This article contrasts the presentation of cancer, infections, and fractures with the more common and benign conditions that cause back pain and provides guidance for diagnosis.

UNCOMMON, BUT MUST BE CONSIDERED

Although a variety of tissues can contribute to pain—intervertebral disks, vertebrae, ligaments, neural structures, muscles, and fascia—and many disorders can damage these tissues, most patients with back or neck pain have a benign condition. Back pain is typically caused by age-related degenerative changes or by minor repetitive trauma; with supportive care and physical therapy, up to 90% of patients with back pain of this nature improve substantially within 4 weeks.2

Serious, destructive diseases are uncommon causes of back pain: malignancy, infection, ankylosing spondylitis, and epidural abscess together account for fewer than 1% of cases of back pain in a typical primary care practice. But their clinical impact is out of proportion to their prevalence. The fear of overlooking a serious condition influences any practitioner’s approach to back pain and is a common reason for ordering multiple imaging studies and consultations.3 Therefore, the time, effort, and resources invested in ruling out these disorders is considerable.

Whether a patient with back pain has an ominous disease can usually be determined with a careful history, physical examination, and appropriate diagnostic studies. Once a serious diagnosis is ruled out, attention can be focused on rehabilitation and back care.

Back pain can also be due to musculoskeletal disorders, peptic ulcers, pancreatitis, pyelonephritis, aortic aneurysms, and other serious conditions, which we have discussed in other articles in this journal.4–6

SPINAL CANCER AND METASTASES

Since back pain is the presenting symptom in 90% of patients with spinal tumors,7 neoplasia belongs in the differential diagnosis of any patient with persistent, unremitting back pain. However, it is also important to recognize atypical presentations of neoplasia, such as a painless neurologic deficit, which should prompt an urgent workup.

The spine is one of the most common sites of metastasis: about 20,000 cases arise each year.8 Brihaye et al9 reviewed 1,477 cases of spinal metastases with epidural involvement and found that 16.5% arose from primary tumors in the breast, 15.6% from the lung, 9.2% from the prostate, and 6.5% from the kidney.

Cancer pain is persistent and progressive

Pain from spinal cancer is often different from idiopathic back pain or degenerative disk disease (Table 1).

Benign back pain often arises from a known injury, is relieved by rest, and increases with activities that load the disk (eg, sitting, getting up from bed or a chair), lumbar flexion with or without rotation, lifting, vibration (eg, riding in a car), coughing, sneezing, laughing, and the Valsalva maneuver. It is most commonly focal to the lumbosacral junction, the lumbar muscles, and the buttocks. Pain due to injury or a flare-up of degenerative disease typically begins to subside after 4 to 6 weeks and responds to nonsteroidal anti-inflammatory drugs and physical therapy.10

In contrast, pain caused by spinal neoplasia is typically persistent and progressive and is not alleviated by rest. Often the pain is worse at night, waking the patient from sleep. Back pain is typically focal to the level of the lesion and may be associated with belt-like thoracic pain or radicular symptoms of pain or weakness in the legs. A spinal mass can cause neurologic signs or symptoms by directly compressing the spinal cord or nerve roots, mimicking disk herniation or stenosis.11,12

Pathologic fractures resulting from vertebral destruction may be the first—and unfortunately a late—presentation of a tumor.

Ask about, look for, signs and symptoms of cancer

In taking the history, one should ask about possible signs and symptoms of systemic disease such as fatigue, weight loss, and changes in bowel habits. Hemoptysis, lymphadenopathy, subcutaneous or breast masses, nipple discharge, atypical vaginal bleeding, or blood in the stool suggest malignancy and should direct the specific diagnostic approach.13 A history of cancer, even if remote, should raise suspicion, as should major risk factors such as smoking.

Because most spinal tumors are metastases, a clinical examination of the breast, lungs, abdomen, thyroid, and prostate are appropriate starting points.14 The spine should be examined to identify sites of focal pain. A neurologic examination should be done to evaluate any signs of neurologic compromise or abnormal reflexes. Signs or symptoms of spinal cord compression should be investigated immediately.

 

 

Cancer usually elevates the ESR, CRP

If cancer is suspected, initial tests should include a complete blood cell count, erythrocyte sedimentation rate, C-reactive protein level, urinalysis, prostate-specific antigen level, and fecal occult blood testing. Normal results can considerably relieve suspicion of cancer: the erythrocyte sedimentation rate and C-reactive protein level are almost always elevated with systemic neoplasia.

Figure 1. A 43-year-old man with a 2-week history of progressive back pain and an abdominal mass. Sagittal CT scan shows an osteolytic lesion of the L3 vertebral body (arrow). The primary tumor was renal. Fracture of the vertebral end plate (arrowheads) may cause first symptoms of pain.
Other initial tests include a complete blood cell count and chemistry panel. If laboratory studies reveal anemia, hypercalcemia, and elevated levels of alkaline phosphatase, concern should increase. Chest radiography, abdominal computed tomography (CT) (Figure 1), and mammography for women are needed if laboratory results are abnormal. Plain radiographs are the first imaging study of the spine to obtain. Compression fractures, soft tissue calcifications, or focal loss of bone mineralization suggests tumor. Abnormal results on serum and urine protein electrophoresis increase the likelihood of multiple myeloma or plasmacytoma, but normal results do not rule out monoclonal gammopathy of uncertain significance.

Imaging tests

Unfortunately, spinal tumors cannot be well visualized on radiographs until significant destruction has occurred.15

A bone scan can usually detect tumors other than the purely lytic ones such as myeloma and has a sensitivity of 74%, a specificity of 81%, and a positive predictive value of 64% for vertebral metastasis in patients with back pain.16

Figure 2. A 63-year-old woman with history of hepatocellular carcinoma who presented with bilateral leg weakness and debilitating back pain. T2-weighted MRI shows pathologic compression fracture of the L2 vertebral body with retropulsion of fracture fragments into the canal and severe central canal stenosis (arrow).
Magnetic resonance imaging (MRI) is the best imaging study for evaluating spinal tumors because it can show the status of the bone marrow and has excellent contrast resolution in soft tissue (Figure 2).17,18 It can show vertebral bone marrow infiltration by tumor cells as well as soft tissue masses in and around the spinal column. Bone marrow invaded by a neoplasm is characterized by increased cellularity, resulting in a decreased signal on T1-weighted images and a high signal on T2-weighted images. Intravenous gadolinium further increases the contrast between a tumor and normal tissues and is important for characterizing and grading tumors.19

INFECTION CAN BE INDOLENT OR ACUTE

Spinal infection is a serious condition that can take an indolent, smoldering course or, alternatively, can erupt into sepsis or rapidly progressive vertebral destruction. Although the latter conditions are hard to miss, early diskitis and osteomyelitis can be difficult to differentiate from idiopathic back pain. In a series of 101 patients with vertebral osteomyelitis, misdiagnosis occurred in 33.7%, and the average delay from the onset of clinical manifestations to diagnosis was 2.6 months.20 Tuberculosis can be even more elusive: in a series of 78 patients diagnosed with definite or probable tuberculous vertebral osteomyelitis, the mean delay to diagnosis was about 6 months.21

Acute spinal infections are most often pyogenic; chronic infections may be pyogenic, fungal, or granulomatous.

Vertebral osteomyelitis accounts for 2% to 7% of all cases of osteomyelitis and is an uncommon cause of back pain.22 Any source of infection (eg, dental abscess, pneumonia) can seed the spine; urinary tract infection is the most common. Patients with immunocompromise or diabetes are most at risk.23 The onset is usually insidious with focal back pain at the level of involvement.

History and physical examination reveal localized pain

Spinal infections typically cause pain that is worsened with weight-bearing and activity and is relieved only when lying down. Chronic infection is usually associated with weight loss, fatigue, fevers, and night sweats.

Pain is usually well localized and reproduced by palpation or percussion over the involved level. Severe pain can sometimes be elicited by sitting the patient up or by changing the patient’s position. Focal kyphosis may be detectable if the vertebra has collapsed.

In a series of 41 patients with pyogenic infectious spondylitis, 90% had localized back pain aggravated by percussion, 59% had radicular signs and symptoms, and 29% had neurologic signs of spinal cord compression, including hyperreflexia, clonus, the Babinski sign (extension of the toes upward when the sole of the foot is stroked upwards), or the Hoffmann sign (flexion of the thumb elicited by flicking the end of a middle finger).24

LABORATORY RESULTS TYPICALLY INDICATE INFECTION

The erythrocyte sedimentation rate is the most sensitive test for infection, and an elevated rate may be the only abnormal laboratory finding: Digby and Kersley25 found that the rate was increased in all of 30 patients with nontuberculous pyogenic osteomyelitis of the spine. The C-reactive protein level is also usually elevated, but 40% of patients have a normal white blood cell count.25 Results of other laboratory tests are typically in the normal range. Tuberculin skin testing should be done for patients at high risk of the disease (eg, immigrants from areas of endemic disease, non-Hispanic blacks, immunocompromised patients, and those with known exposure to tuberculosis). Patients with high fever, chills, or rigors should have cultures taken of blood, urine, and sputum and from any intravenous lines.

Imaging changes may not appear for months

Figure 3. A 32-year-old woman with systemic lupus erythematosus who is on chronic steroid therapy and who has a 6-week history of back pain. T2-weighted sagittal MRI shows a disk space infection at L2–L3, with ventral paraspinal soft tissue enhancement consistent with early abscess formation (arrows).
Radiographic findings characteristic of osteomyelitis are not apparent for at least 4 to 8 weeks after the onset of infection.26 Narrowing of the disk space is the earliest and most consistent finding but is nonspecific.27 Pyogenic infection is often heralded by rapid disk destruction and disk space narrowing. MRI is as accurate and sensitive as nuclear medicine scanning (sensitivity 96%, specificity 93%, accuracy 94%).28 MRI can help differentiate degenerative and neoplastic disease from vertebral osteomyelitis29 and provides better imaging than CT for soft-tissue infections (Figure 3).

CT, on the other hand, may be better for showing the extent of bone involvement. In cases of vertebral osteomyelitis and intervertebral disk space infection, simultaneous involvement of the adjacent vertebral end plates and the intervertebral disk are the major findings.30

Signs of infection using T1-weighted MRI include low-signal marrow or disk spaces within the vertebral body, loss of definition of end plates (which appear hypointense compared with the bone marrow), and destruction of the cortical margins of the involved vertebral bodies. T2-weighted MRI typically discloses high signals of the affected areas of the vertebral body and disk. Contrast should be used to increase specificity; enhancement may be the first sign of an acute inflammatory process.31

CT and MRI can help identify sequestra, perilesional sclerosis, and epidural or soft tissue abscesses. Guided biopsy may be needed to differentiate between abscess, hematoma, tumor, and inflammation.

 

 

MRI findings: Pyogenic vs tuberculous spondylitis

MRI can help differentiate pyogenic vertebral osteomyelitis from tubercular disease, although findings may be similar (eg, both conditions have a high signal on T2-weighted images).32 Jung et al,33 in a retrospective study of 52 patients with spondylitis, found that compared with patients with pyogenic infections, patients with tuberculous spondylitis had a significantly higher incidence of a well-defined paraspinal abnormal signal on MRI, a thin and smooth abscess wall, a paraspinal or intraosseous abscess, subligamentous spread to three or more vertebral levels, involvement of multiple vertebral bodies, thoracic spine involvement, and a hyperintense signal on T2-weighted images. Other MRI features characteristically seen in patients with tuberculous spinal disease are anterior corner destruction, a relative preservation of the intervertebral disk, and large soft-tissue abscesses with calcifications.34

Prompt diagnosis and aggressive treatment needed

Pigrau et al35 found that spinal osteomyelitis is highly associated with endocarditis: among 606 patients with infectious endocarditis, 28 (4.6%) had pyogenic vertebral osteomyelitis, and among 91 patients with pyogenic vertebral osteomyelitis, 28 (30.8%) had infectious endocarditis.

McHenry et al36 retrospectively studied outcomes of 253 patients with vertebral osteomyelitis after a median of 6.5 years (range 2 days to 38 years): 11% died, more than one-third of survivors had residual disability, and 14% had a relapse. Surgery resulted in recovery or improvement in 86 (79%) of 109 patients. Independent risk factors for adverse outcome (death or incomplete recovery) were neurologic compromise, increased time to diagnosis, and having a hospital-acquired infection (P = .004). Relapse commonly developed in patients with severe vertebral destruction and abscesses, which appeared some time after surgical drainage or debridement. Recurrent bacteremia, paravertebral abscesses, and chronically draining sinuses were independently associated with relapse (P = .001). MRI, done in 110 patients, was often performed late in the course of infection and did not significantly affect outcome. The authors stressed that an optimal outcome of vertebral osteomyelitis requires heightened awareness, early diagnosis, prompt identification of pathogens, reversal of complications, and prolonged antimicrobial therapy.

Epidural abscess may also be present

Epidural abscess occurs in 10% of spine infections. About half of patients with an epidural abscess are misdiagnosed on their initial evaluation.37,38 Patients initially complain of local spine pain, followed by radicular pain, weakness, and finally paralysis. Between 12% and 30% of patients report a history of trauma, even as minor as a fall, preceding the infection.38,39

Radiologic findings are frequently equivocal, and MRI is preferred; gadolinium enhancement further increases sensitivity.39,40 Spinal canal abscesses usually appear hypointense on T1-weighted images and hyperintense on T2-weighted images, with ring enhancement surrounding the abscess area in contrast studies.41 MRI may give negative findings in the early stages of a spinal canal infection and so may need to be repeated.41 MRI may not help distinguish an epidural from a subdural abscess. However, primary spinal epidural abscesses without concomitant vertebral osteomyelitis are rare; therefore, the finding of associated vertebral osteomyelitis makes a spinal epidural abscess more likely.

FRACTURES

Fractures of the spine can be asymptomatic and may have no preceding trauma. They can be due to osteoporosis, malignancy, infection, or metabolic disorders such as renal osteodystrophy or hyperparathyroidism. Fractures in normal bone are almost always associated with trauma. Any suspicion of infection or malignancy should be investigated.

Corticosteroids increase risk

Any patient with back pain who is receiving corticosteroid therapy should be considered as having a compression fracture until proven otherwise.3 De Vries et al42 found that in a database of nearly 200,000 patients receiving glucocorticoids, risk increased substantially with increasing cumulative exposure. Those who intermittently received high doses (= 15 mg/day) and those who had no or little previous exposure to corticosteroids (cumulative exposure = 1 g) had only a slightly increased risk of osteoporotic fracture, and their risk of fracture of the hip and femur was not increased. In contrast, patients who received a daily dose of at least 30 mg and whose cumulative exposure was more than 5 g had a relative risk of osteoporotic vertebral fracture of 14.42 (95% confidence interval 8.29–25.08).

Osteoporotic compression fractures are common in the elderly

Osteoporosis involves reduced bone density, disrupted trabecular architecture, and increased susceptibility to fractures. About 700,000 vertebral body compression fractures occur in the United States each year43: about 10% result in hospitalization, involving an average stay of 8 days.44 Osteoporotic compression fractures are highly associated with age older than 65, female sex, and European descent.45,46 The estimated lifetime risk of a clinically evident vertebral fracture after age 50 years is 16% among postmenopausal white women and 5% among white men.47

A single osteoporotic vertebral compression fracture increases the risk of subsequent fractures by a factor of five, and up to 20% of patients with a vertebral compression fracture are likely to have another one within the same year if osteoporosis remains untreated.48 Population studies suggest that the death rate among patients who have osteoporotic vertebral compression fractures increases with the number of involved vertebrae.43

Unfortunately, osteoporotic vertebral compression fractures are not always easily amenable to treatment: up to 30% of patients who are symptomatic and seek treatment do not respond adequately to nonsurgical methods.49,50 However, new minimally invasive interventions such as vertebral augmentation make timely evaluation clinically relevant.

 

 

History, physical examination

Patients may present with a history of trauma with associated back pain or a neurologic deficit. In osteoporotic patients, the trauma may have been minimal, eg, a sneeze, a fall from a chair, or a slip and fall in the home. Pain tends to be worse when standing erect and occasionally when lying flat.

The patient is commonly visibly uncomfortable and may be limited to a wheelchair or stoop forward when standing. The spine may show an absence of the midline crease or an exaggerated thoracic kyphosis. Pain is typically reproduced by deep pressure over the spinous process at the involved level. Compression fractures rarely cause neurologic deficits but should always be considered.

Fractures commonly occur in the thoracolumbar region but may be anywhere in the spine. Fractures in the upper thoracic spine may indicate an underlying malignant tumor, and a thorough search for a possible primary lesion should always be carried out for fractures in this location.

Laboratory testing

Routine laboratory evaluation and thyroid function tests should be done, as well as a 24-hour urine specimen for collagen breakdown products, calcium, phosphate, and creatinine levels. Serum and urine protein electrophoresis should be performed if myeloma is suspected. A white blood-cell count, erythrocyte sedimentation rate, and C-reactive protein level help determine if an underlying infection caused the fracture.

MRI needed if plain films reveal fracture or are equivocal

Anteroposterior and lateral roentgenograms should be taken first; they typically show osteopenia. A fracture in the vertebral body is characterized by loss of height and by wedging. Osseous fragments can occasionally be seen in the spinal canal.

If a fracture is diagnosed or the radiographs are equivocal, MRI of the spine should be done next, since it is probably best for determining fracture age, detecting a malignant tumor (Table 2), and helping select appropriate treatment. Shortly after a vertebral fracture, MRI shows a geographic pattern of low-intensity signal changes on T1-weighted images and high-intensity signal changes on T2-weighted images. As a fracture becomes chronic, a linear area of low-intensity signal change replaces the geographic area on T1-weighted images. As healing continues, the linear pattern is replaced by restoration of fatty marrow.51

Sagittal short tau inversion recovery sequences, which use specifically timed pulse sequences to suppress fat signals, show high-intensity signal changes in areas of edema from acute or healing fractures. They provide a sensitive but nonspecific marker of abnormality.

Dual energy x-ray absorptiometry helps determine the extent of osteoporosis.

Bone scans should only be used for patients with suspected metastatic disease.

Patients with ankylosing spondylitis need thorough workup

Ankylosing spondylitis predisposes to serious spinal injury. Even after only minor trauma, patients with ankylosing spondylitis and acute, severe back pain should be thoroughly evaluated for fracture with CT and MRI of the entire spine. Plain radiography should not be relied on for these patients because of the risk of misinterpretation, delayed diagnosis, and poorer outcomes.52,53

NEUROLOGIC COMPROMISE—A RED FLAG

Neural compromise can result from spinal cord or cauda equina compression (Table 3). Cauda equina compression usually results from a fracture, tumor, epidural hematoma, or abscess, and occasionally from massive disk herniation. Paraplegia, quadriplegia, or cauda equina deficit should trigger an aggressive search for the cause.54

Cauda equina compression classically presents with back pain, bilateral sciatica, saddle anesthesia, and lower extremity weakness progressing to paraplegia, but in practice these symptoms are variably present and diagnosing the condition often requires a high degree of suspicion. Hyporeflexia is typically a sign of cauda equina compression, while hyperreflexia, clonus, and the Babinski sign suggest spinal cord compression, requiring an evaluation of the cervical and thoracic spine. Cauda equina compression typically involves urinary retention; in contrast, cord compression typically causes incontinence.55

If either cauda equina or spinal cord compression is detected during an initial examination, an immediate more extensive evaluation is warranted. MRI is the study of choice.

Spinal epidural hematoma

Spinal epidural hematoma is a rare but dramatic cause of paralysis in elderly patients. In most cases, there is no antecedent trauma. Lawton et al,56 in a series of 30 patients treated surgically for spinal epidural hematoma, found that 73% resulted from spine surgery, epidural catheterization, or anticoagulation therapy. Other possible causes of epidural hematoma include vascular malformations, angiomas, aneurysms, hypertension, and aspirin therapy.57

The same study56 found that the time from the first symptom to maximal neurologic deficit ranged from a few minutes to 4 days, with the average interval being nearly 13 hours.

Although painless onset has been reported,58 spinal epidural hematoma typically presents with acute pain at the level of the lesion, which is often rapidly followed by paraplegia or quadriplegia, depending on the location of the hemorrhage. Sometimes the onset of pain is preceded by a sudden increase of venous pressure from coughing, sneezing, or straining at stool. Urinary retention often develops at an early stage.

Most lesions occur in the thoracic region and extend into the cervicothoracic or the thoracolumbar area. The pain distribution may be radicular, mimicking a ruptured intervertebral disk.

Evaluation should be with MRI. Acute hemorrhage is characterized by a marked decrease in signal intensity on T2-weighted images. Subacute hematoma has increased signal intensity on both T1- and T2-weighted images.56

Early recognition, MRI confirmation, and treatment should be accomplished as soon as possible.56 Recovery depends on the severity of the neurologic deficit and the duration of symptoms before treatment. Lawton et al56 found that patients taken to surgery within 12 hours had better neurologic outcomes than patients with identical preoperative neurologic status whose surgery was delayed beyond 12 hours. Surgery should not be withheld because of advanced age or poor health: in 10 reported cases in which surgery was delayed, all patients died.59

References
  1. Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine 1987; 12:264268.
  2. Pengel LH, Herbert RD, Maher CG, Refshauge KM. Acute back pain: systematic review of its prognosis. BMJ 2003; 327:323325.
  3. Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about back pain? JAMA 1992; 268:760765.
  4. Pateder DB, Brems J, Lieberman I, Bell GR, McLain RF. Masquerade: nonspinal musculoskeletal disorders that mimic spinal conditions. Cleve Clin J Med 2008; 75:5056.
  5. Klineberg E, Mazanec D, Orr D, Demicco R, Bell G, McLain R. Masquerade: medical causes of back pain. Cleve Clin J Med 2007; 74:905913.
  6. McLain RF, Bell G, Montgomery W. Masquerade: systemic causes of back pain. Cleve Clin J Med In press.
  7. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978; 3:4051.
  8. Black P. Spinal metastasis: current status and recommended guidelines for management. Neurosurgery 1979; 5:726746.
  9. Brihaye J, Ectors P, Lemort M, Van Houtte P. The management of spinal epidural metastases. Adv Tech Stand Neurosurg 1988; 16:121176.
  10. Patel RK, Slipman CW. Lumbar degenerative disk disease. Emedicine. Accessed March 25, 2008. http://www.emedicine.com/pmr/topic67.htm.
  11. Deyo RA, Diehl AK. Cancer as a cause of back pain: frequency, clinical presentation, and diagnostic strategies. J Gen Intern Med 1988; 3:230238.
  12. Rosen P, Barkin RM, Danzl DF, et al. Emergency Medicine: Concepts and Clinical Practice. 4th ed. St Louis, MO: Mosby; 1998:21002102.
  13. Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 1995; 13:20942103.
  14. McCarthy EF, Frassica FJ. Pathology of Bone and Joint Disorders: With Clinical and Radiographic Correlation. Philadelphia: WB Saunders; 1998.
  15. Edelstyn GA, Gillespie PJ, Grebbell FS. The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol 1967; 18:158162.
  16. Han LJ, Au-Yong TK, Tong WC, Chu KS, Szeto LT, Wong CP. Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain. Eur J Nucl Med 1998; 25:635638.
  17. Feun LG, Savaraj N. Detection of occult bone metastasis by MRI scan. J Fla Med Assoc 1990; 77:881883.
  18. Citrin DL, Bessent RG, Greig WR. A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol 1977; 28:107117.
  19. Runge VM, Lee C, Iten AL, Williams NM. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model. Invest Radiol 1997; 32:589595.
  20. Buranapanitkit B, Lim A, Geater A. Misdiagnosis in vertebral osteomyelitis: problems and factors. J Med Assoc Thai 2001; 84:17431750.
  21. Colmenero JD, Jiménez-Mejías ME, Reguera JM, et al. Tuberculous vertebral osteomyelitis in the new millennium: still a diagnostic and therapeutic challenge. Eur J Clin Microbiol Infect Dis 2004; 23:477483.
  22. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N Engl J Med 1970; 282:316322.
  23. Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am 1997; 79:874880.
  24. Kapeller P, Fazekas F, Krametter D, et al. Pyogenic infectious spondylitis: clinical, laboratory and MRI features. Eur Neurol 1997; 38:9498.
  25. Digby JM, Kersley JB. Pyogenic non-tuberculous spinal infection: an analysis of thirty cases. J Bone Joint Surg Br 1979; 61:4755.
  26. Modic MT, Feiglin DH, Piraino DW, et al. Vertebral osteomyelitis: assessment using MR. Radiology 1985; 157:157166.
  27. Szypryt EP, Hardy JG, Hinton CE, Worthington BS, Mulholland RC. A comparison between magnetic resonance imaging and scintigraphic bone imaging in the diagnosis of disk space infection in an animal model. Spine 1988; 13:10421048.
  28. Küker W, Mull M, Mayfrank L, Töpper R, Thron A. Epidural spinal infection. Variability of clinical and magnetic resonance imaging findings. Spine 1997; 22:544551.
  29. Tung GA, Yim JW, Mermel LA, Philip L, Rogg JM. Spinal epidural abscess: correlation between MRI findings and outcome. Neuroradiology 1999; 41:904909.
  30. Sapico FL, Montgomerie JZ. Vertebral osteomyelitis. Infect Dis Clin North Am 1990; 4:539550.
  31. Tali ET. Spinal infections. Eur J Radiol 2004; 50:120133.
  32. Smith AS, Weinstein MA, Mizushima A, et al. MR imaging characteristics of tuberculous spondylitis vs vertebral osteomyelitis. AJR Am J Roentgenol 1989; 153:399405.
  33. Jung NY, Jee WH, Ha KY, Park CK, Byun JY. Discrimination of tuberculous spondylitis from pyogenic spondylitis on MRI. AJR Am J Roentgenol 2004; 182:14051410.
  34. Joseffer SS, Cooper PR. Modern imaging of spinal tuberculosis. J Neurosurg Spine 2005; 2:145150.
  35. Pigrau C, Almirante B, Flores X, et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. Am J Med 2005; 118:1287.
  36. McHenry MC, Easley KA, Locker GA. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis 2002; 34:13421350.
  37. Danner RL, Hartman BJ. Update on spinal epidural abscess: 35 cases and review of the literature. Rev Infect Dis 1987; 9:265274.
  38. Kaufman DM, Kaplan JG, Litman N. Infectious agents in spinal epidural abscesses. Neurology 1980; 30:844850.
  39. Rezai AR, Woo HH, Errico TJ, Cooper PR. Contemporary management of spinal osteomyelitis. Neurosurgery 1999; 44:10181026.
  40. Bertino RE, Porter BA, Stimac GK, Tepper SJ. Imaging spinal osteomyelitis and epidural abscess with short TI inversion recovery (STIR). AJNR Am J Neuroradiol 1988; 9:563564.
  41. Rigamonti D, Liem L, Sampath P, et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol 1999; 52:189197.
  42. De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 2007; 56:208214.
  43. Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 1992; 7:221227.
  44. Kim DH, Vaccaro AR. Osteoporotic compression fractures of the spine; current options and considerations for treatment. Spine J 2006; 6:479487.
  45. Cohn SH, Abesamis C, Yasumura S, Aloia JF, Zanzi I, Ellis KJ. Comparative skeletal mass and radial bone mineral content in black and white women. Metabolism 1977; 26:171178.
  46. Tobias JH, Hutchinson AP, Hunt LP, et al. Use of clinical risk factors to identify postmenopausal women with vertebral fractures. Osteoporos Int 2007; 18:3543.
  47. Melton LJ, Kallmes DF. Epidemiology of vertebral fractures: implications for vertebral augmentation. Acad Radiol 2006; 13:538545.
  48. Silverman SL. The clinical consequences of vertebral compression fracture. Bone 1992; 13:S27S31.
  49. Melton LJ, Kan SH, Frye MA, Wahner HW, O’Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989; 129:10001011.
  50. Wasnich RD. Vertebral fracture epidemiology. Bone 1996; 18:179S183S.
  51. Yamato M, Nishimura G, Kuramochi E, Saiki N, Fujioka M. MR appearance at different ages of osteoporotic compression fractures of the vertebrae. Radiat Med 1998; 16:329334.
  52. Einsiedel T, Schmelz A, Arand M, et al. Injuries of the cervical spine in patients with ankylosing spondylitis: experience at two trauma centers. J Neurosurg Spine 2006; 5:3345.
  53. Olerud C, Frost A, Bring J. Spinal fractures in patients with ankylosing spondylitis. Eur Spine J 1996; 5:5155.
  54. Spangfort EV. The lumbar disk herniation. A computer-aided analysis of 2,504 operations. Acta Orthop Scand Suppl 1972; 142:195.
  55. Kostuik JP, Harrington I, Alexander D, Rand W, Evans D. Cauda equina syndrome and lumbar disk herniation. J Bone Joint Surg Am 1986; 68:386391.
  56. Lawton MT, Porter RW, Heiserman JE, Jacobowitz R, Sonntag VK, Dickman CA. Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome. J Neurosurg 1995; 83:17.
  57. Simmons EH, Grobler LJ. Acute spinal epidural hematoma. J Bone Joint Surg Am 1978; 60:395396.
  58. Senelick RC, Norwood CW, Cohen GH. “Painless” spinal epidural hematoma during anticoagulant therapy”. Neurology 1976; 26:213225.
  59. Watts C, Porto L. Recognizing spontaneous spinal epidural hematoma. Geriatrics 1976; 31:9799.
References
  1. Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine 1987; 12:264268.
  2. Pengel LH, Herbert RD, Maher CG, Refshauge KM. Acute back pain: systematic review of its prognosis. BMJ 2003; 327:323325.
  3. Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about back pain? JAMA 1992; 268:760765.
  4. Pateder DB, Brems J, Lieberman I, Bell GR, McLain RF. Masquerade: nonspinal musculoskeletal disorders that mimic spinal conditions. Cleve Clin J Med 2008; 75:5056.
  5. Klineberg E, Mazanec D, Orr D, Demicco R, Bell G, McLain R. Masquerade: medical causes of back pain. Cleve Clin J Med 2007; 74:905913.
  6. McLain RF, Bell G, Montgomery W. Masquerade: systemic causes of back pain. Cleve Clin J Med In press.
  7. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978; 3:4051.
  8. Black P. Spinal metastasis: current status and recommended guidelines for management. Neurosurgery 1979; 5:726746.
  9. Brihaye J, Ectors P, Lemort M, Van Houtte P. The management of spinal epidural metastases. Adv Tech Stand Neurosurg 1988; 16:121176.
  10. Patel RK, Slipman CW. Lumbar degenerative disk disease. Emedicine. Accessed March 25, 2008. http://www.emedicine.com/pmr/topic67.htm.
  11. Deyo RA, Diehl AK. Cancer as a cause of back pain: frequency, clinical presentation, and diagnostic strategies. J Gen Intern Med 1988; 3:230238.
  12. Rosen P, Barkin RM, Danzl DF, et al. Emergency Medicine: Concepts and Clinical Practice. 4th ed. St Louis, MO: Mosby; 1998:21002102.
  13. Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 1995; 13:20942103.
  14. McCarthy EF, Frassica FJ. Pathology of Bone and Joint Disorders: With Clinical and Radiographic Correlation. Philadelphia: WB Saunders; 1998.
  15. Edelstyn GA, Gillespie PJ, Grebbell FS. The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol 1967; 18:158162.
  16. Han LJ, Au-Yong TK, Tong WC, Chu KS, Szeto LT, Wong CP. Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain. Eur J Nucl Med 1998; 25:635638.
  17. Feun LG, Savaraj N. Detection of occult bone metastasis by MRI scan. J Fla Med Assoc 1990; 77:881883.
  18. Citrin DL, Bessent RG, Greig WR. A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol 1977; 28:107117.
  19. Runge VM, Lee C, Iten AL, Williams NM. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model. Invest Radiol 1997; 32:589595.
  20. Buranapanitkit B, Lim A, Geater A. Misdiagnosis in vertebral osteomyelitis: problems and factors. J Med Assoc Thai 2001; 84:17431750.
  21. Colmenero JD, Jiménez-Mejías ME, Reguera JM, et al. Tuberculous vertebral osteomyelitis in the new millennium: still a diagnostic and therapeutic challenge. Eur J Clin Microbiol Infect Dis 2004; 23:477483.
  22. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N Engl J Med 1970; 282:316322.
  23. Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am 1997; 79:874880.
  24. Kapeller P, Fazekas F, Krametter D, et al. Pyogenic infectious spondylitis: clinical, laboratory and MRI features. Eur Neurol 1997; 38:9498.
  25. Digby JM, Kersley JB. Pyogenic non-tuberculous spinal infection: an analysis of thirty cases. J Bone Joint Surg Br 1979; 61:4755.
  26. Modic MT, Feiglin DH, Piraino DW, et al. Vertebral osteomyelitis: assessment using MR. Radiology 1985; 157:157166.
  27. Szypryt EP, Hardy JG, Hinton CE, Worthington BS, Mulholland RC. A comparison between magnetic resonance imaging and scintigraphic bone imaging in the diagnosis of disk space infection in an animal model. Spine 1988; 13:10421048.
  28. Küker W, Mull M, Mayfrank L, Töpper R, Thron A. Epidural spinal infection. Variability of clinical and magnetic resonance imaging findings. Spine 1997; 22:544551.
  29. Tung GA, Yim JW, Mermel LA, Philip L, Rogg JM. Spinal epidural abscess: correlation between MRI findings and outcome. Neuroradiology 1999; 41:904909.
  30. Sapico FL, Montgomerie JZ. Vertebral osteomyelitis. Infect Dis Clin North Am 1990; 4:539550.
  31. Tali ET. Spinal infections. Eur J Radiol 2004; 50:120133.
  32. Smith AS, Weinstein MA, Mizushima A, et al. MR imaging characteristics of tuberculous spondylitis vs vertebral osteomyelitis. AJR Am J Roentgenol 1989; 153:399405.
  33. Jung NY, Jee WH, Ha KY, Park CK, Byun JY. Discrimination of tuberculous spondylitis from pyogenic spondylitis on MRI. AJR Am J Roentgenol 2004; 182:14051410.
  34. Joseffer SS, Cooper PR. Modern imaging of spinal tuberculosis. J Neurosurg Spine 2005; 2:145150.
  35. Pigrau C, Almirante B, Flores X, et al. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. Am J Med 2005; 118:1287.
  36. McHenry MC, Easley KA, Locker GA. Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis 2002; 34:13421350.
  37. Danner RL, Hartman BJ. Update on spinal epidural abscess: 35 cases and review of the literature. Rev Infect Dis 1987; 9:265274.
  38. Kaufman DM, Kaplan JG, Litman N. Infectious agents in spinal epidural abscesses. Neurology 1980; 30:844850.
  39. Rezai AR, Woo HH, Errico TJ, Cooper PR. Contemporary management of spinal osteomyelitis. Neurosurgery 1999; 44:10181026.
  40. Bertino RE, Porter BA, Stimac GK, Tepper SJ. Imaging spinal osteomyelitis and epidural abscess with short TI inversion recovery (STIR). AJNR Am J Neuroradiol 1988; 9:563564.
  41. Rigamonti D, Liem L, Sampath P, et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol 1999; 52:189197.
  42. De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 2007; 56:208214.
  43. Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 1992; 7:221227.
  44. Kim DH, Vaccaro AR. Osteoporotic compression fractures of the spine; current options and considerations for treatment. Spine J 2006; 6:479487.
  45. Cohn SH, Abesamis C, Yasumura S, Aloia JF, Zanzi I, Ellis KJ. Comparative skeletal mass and radial bone mineral content in black and white women. Metabolism 1977; 26:171178.
  46. Tobias JH, Hutchinson AP, Hunt LP, et al. Use of clinical risk factors to identify postmenopausal women with vertebral fractures. Osteoporos Int 2007; 18:3543.
  47. Melton LJ, Kallmes DF. Epidemiology of vertebral fractures: implications for vertebral augmentation. Acad Radiol 2006; 13:538545.
  48. Silverman SL. The clinical consequences of vertebral compression fracture. Bone 1992; 13:S27S31.
  49. Melton LJ, Kan SH, Frye MA, Wahner HW, O’Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989; 129:10001011.
  50. Wasnich RD. Vertebral fracture epidemiology. Bone 1996; 18:179S183S.
  51. Yamato M, Nishimura G, Kuramochi E, Saiki N, Fujioka M. MR appearance at different ages of osteoporotic compression fractures of the vertebrae. Radiat Med 1998; 16:329334.
  52. Einsiedel T, Schmelz A, Arand M, et al. Injuries of the cervical spine in patients with ankylosing spondylitis: experience at two trauma centers. J Neurosurg Spine 2006; 5:3345.
  53. Olerud C, Frost A, Bring J. Spinal fractures in patients with ankylosing spondylitis. Eur Spine J 1996; 5:5155.
  54. Spangfort EV. The lumbar disk herniation. A computer-aided analysis of 2,504 operations. Acta Orthop Scand Suppl 1972; 142:195.
  55. Kostuik JP, Harrington I, Alexander D, Rand W, Evans D. Cauda equina syndrome and lumbar disk herniation. J Bone Joint Surg Am 1986; 68:386391.
  56. Lawton MT, Porter RW, Heiserman JE, Jacobowitz R, Sonntag VK, Dickman CA. Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome. J Neurosurg 1995; 83:17.
  57. Simmons EH, Grobler LJ. Acute spinal epidural hematoma. J Bone Joint Surg Am 1978; 60:395396.
  58. Senelick RC, Norwood CW, Cohen GH. “Painless” spinal epidural hematoma during anticoagulant therapy”. Neurology 1976; 26:213225.
  59. Watts C, Porto L. Recognizing spontaneous spinal epidural hematoma. Geriatrics 1976; 31:9799.
Issue
Cleveland Clinic Journal of Medicine - 75(8)
Issue
Cleveland Clinic Journal of Medicine - 75(8)
Page Number
557-566
Page Number
557-566
Publications
Publications
Topics
Article Type
Display Headline
Identifying serious causes of back pain: Cancer, infection, fracture
Display Headline
Identifying serious causes of back pain: Cancer, infection, fracture
Sections
Inside the Article

KEY POINTS

  • A primary tumor or metastasis to the spine tends to cause unremitting back pain that worsens at night and is accompanied by systemic disease and abnormal laboratory findings.
  • Infection typically causes focal pain, an elevated erythrocyte sedimentation rate (the most sensitive laboratory test) and C-reactive protein level, and sometimes neurologic signs and symptoms.
  • Fractures cause focal pain and should be suspected especially in older white women and patients who take corticosteroids or who have ankylosing spondylitis.
  • Plain radiography can help detect fractures, but magnetic resonance imaging is needed to evaluate spinal tumors, soft tissue infections, and epidural abscesses, and to further evaluate neural compression due to fractures.
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Lumbar Spine Stenosis

Article Type
Changed
Display Headline
Lumbar Spine Stenosis

Article PDF
Author and Disclosure Information

Heidi Tuthill, MD, and Paul D. Clifford, MD

Dr. Tuthill is Radiology Resident, and Dr. Clifford is Clinical Assistant Professor of Radiology, Chief of Musculoskeletal Imaging, Director of MSK Fellowship Program, and Director of MRI Fellowship Program, Department of Radiology, University of Miami Miller School of Medicine, Miami, Florida.

Issue
The American Journal of Orthopedics - 37(8)
Publications
Topics
Page Number
423-424
Legacy Keywords
lumbar, spine, stenosis, spinal canal, neural foramina, parasthesias, degeneration, neurogenic claudication, magnetic resonance, imaging, mri, ajo, american journal of orthopedics
Sections
Author and Disclosure Information

Heidi Tuthill, MD, and Paul D. Clifford, MD

Dr. Tuthill is Radiology Resident, and Dr. Clifford is Clinical Assistant Professor of Radiology, Chief of Musculoskeletal Imaging, Director of MSK Fellowship Program, and Director of MRI Fellowship Program, Department of Radiology, University of Miami Miller School of Medicine, Miami, Florida.

Author and Disclosure Information

Heidi Tuthill, MD, and Paul D. Clifford, MD

Dr. Tuthill is Radiology Resident, and Dr. Clifford is Clinical Assistant Professor of Radiology, Chief of Musculoskeletal Imaging, Director of MSK Fellowship Program, and Director of MRI Fellowship Program, Department of Radiology, University of Miami Miller School of Medicine, Miami, Florida.

Article PDF
Article PDF

Issue
The American Journal of Orthopedics - 37(8)
Issue
The American Journal of Orthopedics - 37(8)
Page Number
423-424
Page Number
423-424
Publications
Publications
Topics
Article Type
Display Headline
Lumbar Spine Stenosis
Display Headline
Lumbar Spine Stenosis
Legacy Keywords
lumbar, spine, stenosis, spinal canal, neural foramina, parasthesias, degeneration, neurogenic claudication, magnetic resonance, imaging, mri, ajo, american journal of orthopedics
Legacy Keywords
lumbar, spine, stenosis, spinal canal, neural foramina, parasthesias, degeneration, neurogenic claudication, magnetic resonance, imaging, mri, ajo, american journal of orthopedics
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media